Global Spatial Transcriptomics Sequencing Market Growth (Status and Outlook) 2026-2032
The global Spatial Transcriptomics Sequencing market size is predicted to grow from US$ 148 million in 2025 to US$ 268 million in 2032; it is expected to grow at a CAGR of 9.0% from 2026 to 2032.
Spatial transcriptomics sequencing is an advanced molecular biology technique that combines the principles of transcriptomics (the study of the complete set of RNA transcripts in a cell or tissue) with spatial information. It enables the simultaneous measurement of gene expression levels and the determination of the location of those transcripts within a tissue sample. By preserving the spatial context of gene expression, this technology provides a more comprehensive understanding of how genes are expressed in different regions of a tissue, which is crucial for elucidating complex biological processes, disease mechanisms, and cellular interactions. It typically involves methods to capture and sequence RNA molecules directly from specific locations within a tissue section, followed by computational analysis to map the gene expression data back to their spatial coordinates.
Key Findings
Spatial Transcriptomics Sequencing links gene-expression measurements with native tissue architecture and cellular location
NGS-Based Capture Spatial Transcriptomics supports broad transcriptome profiling across spatially barcoded tissue areas
In Situ Sequencing-Based Spatial Transcriptomics emphasizes single-cell or subcellular localization and high-plex molecular imaging
Cancer Research Developmental Biology and Neuroscience form the principal application framework of the market
Market Trends
Spatial Transcriptomics Sequencing is progressing toward higher spatial resolution, broader transcript coverage, larger tissue capture areas and more integrated multiomic analysis. Sequencing-based systems are narrowing the historical trade-off between whole-transcriptome breadth and cellular-level localization through denser spatial features, improved barcoding chemistry and scalable sequencing workflows. In situ platforms are simultaneously increasing gene-panel size, imaging area, acquisition speed and compatibility with RNA and protein measurements in the same tissue section. Support for formalin-fixed paraffin-embedded samples is becoming increasingly important because it enables researchers to access archived clinical specimens and connect spatial information with established histopathology. The workflow is also shifting from instrument- or assay-centered purchasing toward complete sample-to-insight solutions combining tissue handling, reagents, sequencing or imaging, data processing, cell segmentation, visualization and biological interpretation. As datasets become larger, computational efficiency, interoperability and standardized quality-control metrics are becoming as important as molecular sensitivity. Longer term, the industry is moving toward reproducible cohort-scale studies, spatial multiomics, three-dimensional tissue reconstruction and closer integration with single-cell sequencing, digital pathology and artificial intelligence-assisted image analysis.
Market Dynamics
Drivers
The principal driver of Spatial Transcriptomics Sequencing is the need to understand biological heterogeneity without losing tissue context. Conventional bulk RNA sequencing averages signals across many cells, while dissociative single-cell methods provide cell-level expression profiles but separate cells from their original locations. Spatial workflows connect molecular states with tumor regions, neural structures, developmental compartments and neighboring cell populations, supporting more detailed analysis of cell interactions and tissue organization. Cancer researchers use the technology to investigate tumor microenvironments, immune-cell distribution, clonal organization and treatment-related changes. Developmental Biology studies use spatial maps to examine organ formation, cell-fate transitions and temporal patterning, while Neuroscience applications benefit from the ability to associate molecularly defined cell types with anatomical regions and neural circuits. Continued investment in genomics, precision medicine, biomarker research and tissue-atlas programs therefore expands the potential customer base across universities, medical centers, pharmaceutical companies and biotechnology developers.
Restraints
Spatial Transcriptomics Sequencing remains technically and economically demanding because results are highly sensitive to tissue quality, sectioning, fixation, permeabilization, staining, probe performance and experimental design. Some workflows require expensive dedicated instruments, proprietary consumables and high-capacity sequencing or imaging infrastructure, limiting adoption by laboratories with irregular sample volumes. Whole-transcriptome assays can generate substantial sequencing, storage and computational requirements, whereas targeted in situ methods require prior selection of genes and may miss unexpected biological signals outside the panel. Differences in spatial resolution, capture efficiency, tissue area, transcript sensitivity and cell-segmentation methodology also make direct comparison among platforms difficult. Sample preparation protocols may need optimization for different organs, species and preservation methods, and unsuccessful tissue processing can result in the loss of scarce clinical material. These factors increase the importance of experienced laboratory personnel and often encourage smaller research groups to outsource projects rather than establish complete internal workflows.
Opportunities
Major opportunities are developing around archived clinical tissue, spatial multiomics, large-cohort research and specialized sequencing services. Greater compatibility with formalin-fixed paraffin-embedded samples can unlock extensive pathology archives for retrospective Cancer Research and translational biomarker programs. Combining spatial RNA measurements with proteins, morphology, genomic alterations or other molecular layers can provide a more complete representation of cell states and tissue interactions than transcript analysis alone. Service providers can expand demand by offering integrated tissue assessment, experimental design, sectioning, staining, assay execution, sequencing, imaging, bioinformatics and biological interpretation, thereby lowering technical barriers for laboratories without dedicated spatial infrastructure. New opportunities also arise from cross-species studies, organoids, regenerative biology, drug-response mapping and preclinical model characterization. Suppliers capable of improving throughput and workflow standardization may support a transition from small exploratory experiments to larger cohort studies and pharmaceutical research programs.
Challenges
The industry must address reproducibility, analytical standardization and biological interpretation as Spatial Transcriptomics Sequencing moves into larger and more decision-relevant studies. Tissue morphology, RNA integrity, capture chemistry, imaging quality, sequencing depth and computational parameters can each influence the final spatial map. Cell segmentation is particularly important for cellular and subcellular workflows because incorrect boundaries can assign transcripts to the wrong cell and distort cell-type or interaction analysis. Batch effects arising from different slides, instruments, laboratories or sample-processing dates can complicate multi-center studies. The lack of universally accepted metrics for comparing sensitivity, effective resolution, transcript recovery and usable tissue area also creates uncertainty for customers evaluating competing technologies. Researchers must additionally manage very large image and molecular datasets while maintaining traceability from raw data to interpreted results. Translation into clinical decision-making will require stronger validation, reproducible operating procedures and evidence that spatial biomarkers provide value beyond conventional pathology and sequencing approaches.
Industry Chain Analysis
The upstream portion of the Spatial Transcriptomics Sequencing industry chain comprises tissue slides and capture substrates, spatial barcodes, oligonucleotide probes, enzymes, antibodies, staining reagents, library-preparation materials, sequencing consumables, imaging components and laboratory automation equipment. It also includes sequencers, high-resolution microscopes, fluidic systems, scanners, servers, cloud-computing resources and software infrastructure. Upstream performance directly influences RNA recovery, optical quality, spatial fidelity, assay reproducibility and usable tissue area. Sample-specific requirements create close interaction among reagent developers, instrument manufacturers, pathology laboratories and sequencing technology providers.
The midstream segment includes spatial platform developers, sequencing-system suppliers and specialized service laboratories that convert tissue samples into spatially resolved expression datasets. Their activities cover sample acceptance, pathology review, tissue optimization, molecular processing, library construction, sequencing or imaging, primary data processing, cell segmentation, spatial clustering and visualization. Downstream users include universities, research institutes, hospitals, pharmaceutical companies, biotechnology enterprises and contract research organizations. Value creation is concentrated in robust sample preparation, dependable molecular sensitivity, resolution, throughput, bioinformatics capability and accurate biological interpretation. Major costs include proprietary reagents, tissue processing, instrument depreciation, sequencing, image acquisition, data storage, computation and specialist labor. Platform suppliers generate value through instruments, consumables and software, while service providers compete through workflow breadth, project experience, turnaround time and analytical support.
Segment Insights
NGS-Based Capture Spatial Transcriptomics is positioned around broad gene-expression discovery and generally integrates tissue imaging with spatially indexed RNA capture, library preparation and next-generation sequencing. Its principal advantage is the ability to profile a large portion of the transcriptome without restricting the experiment to a narrowly predefined gene panel. Denser capture arrays and improved computational binning are enabling increasingly detailed analysis approaching cellular scale, while high-throughput sequencers support expansion into larger tissue areas and sample cohorts. The segment is particularly suitable for discovery research, tissue atlasing and projects in which unexpected pathways or cell states may be important. Its operational requirements include sequencing capacity, substantial data processing and careful coordination between histology and molecular workflows.
In Situ Sequencing-Based Spatial Transcriptomics and related imaging-based approaches measure transcripts within intact tissue through multiplexed cycles of hybridization, imaging or local molecular identification. These technologies provide strong single-cell and subcellular localization, allowing researchers to examine cell boundaries, intracellular transcript distribution and interactions between neighboring cell populations. Targeted panels can offer high sensitivity for selected genes and efficient hypothesis-driven studies, while newer systems are expanding toward substantially broader transcript coverage. The Others segment includes region-of-interest profiling, alternative bead- or array-based capture methods and specialized workflows combining spatial transcriptomics with other molecular measurements. The competitive boundary among segments is becoming less rigid as sequencing-based products improve resolution and imaging-based systems expand gene coverage and tissue throughput.
Downstream Market Opportunities
Cancer Research provides a major downstream opportunity because Spatial Transcriptomics Sequencing can distinguish tumor, stromal and immune compartments while preserving their physical relationships. This supports investigation of intratumoral heterogeneity, immune exclusion, metastatic niches, drug-response mechanisms and candidate spatial biomarkers. Developmental Biology benefits from the ability to reconstruct where cell states emerge and how organs are organized over time, creating opportunities in embryology, regenerative research, organoids and comparative biology. Neuroscience applications use spatial expression maps to classify cell populations across brain regions, connect molecular identity with anatomy and investigate neurological disease. The Other category includes immunology, infectious diseases, cardiovascular research, metabolic disease, fibrosis, tissue engineering and pharmaceutical development. Across these applications, the strongest commercial opportunities arise when technology providers and service laboratories can support complex sample types, provide reliable pathology integration and convert high-dimensional spatial data into interpretable biological conclusions.
Regional Insights
North America represents the most mature commercialization ecosystem for Spatial Transcriptomics Sequencing, supported by a concentration of platform developers, sequencing technology companies, biomedical research institutions, pharmaceutical enterprises and specialist service providers. The region has broad adoption across Cancer Research, translational medicine and neuroscience, and customers can access both instrument-based workflows and outsourced end-to-end services. Continued product launches in sequencing-based and imaging-based spatial systems are expanding competition across resolution, transcript coverage, sample compatibility and analytical software. Europe also has significant capabilities in molecular imaging, in situ analysis, pathology research and pharmaceutical development, with regional demand shaped by academic research networks and translational projects using preserved clinical tissue.
Asia-Pacific has become an important innovation and service-delivery region. China combines domestic spatial technology development with an extensive genomics-service infrastructure, while Japan has established sequencing, biomedical research and clinical-sample processing capabilities. Regional suppliers increasingly offer multiple technical routes rather than a single assay, allowing customers to select workflows according to tissue type, resolution, transcript coverage and research budget. Large population cohorts, active cancer and neuroscience research, and expanding pharmaceutical research create a foundation for future demand. However, adoption varies by country because advanced instruments, specialist pathology resources, computational capacity and research funding remain unevenly distributed.
Competitive Landscape Analysis
The Spatial Transcriptomics Sequencing market has a layered competitive structure comprising platform developers, sequencing infrastructure providers and outsourced multiomics service companies. 10x Genomics, Inc. has established a strong position in NGS-Based Capture Spatial Transcriptomics through its spatially barcoded whole-transcriptome workflows, while Bruker Spatial Biology and Vizgen, Inc. compete in high-plex imaging and cellular or subcellular spatial analysis. Illumina, Inc. is extending its sequencing ecosystem into an end-to-end spatial solution, increasing competition around whole-transcriptome breadth, spatial resolution and workflow scalability. STOmics (BGI Spatial), Resolve Biosciences GmbH and Curio Bioscience, Inc. provide differentiated spatial architectures based on large-area capture, in situ molecular mapping or sequencing-compatible spatial arrays. Takara Bio Inc. participates through its broader molecular biology and sequencing workflow capabilities. Novogene Co., Ltd., Biomarker Technologies Corporation, LC-Bio Technology Co., Ltd., Majorbio Bio-Pharm Technology Co., Ltd., Shanghai Biotechnology Corporation, Annoroad Gene Technology (Beijing) Co., Ltd., OE Biotech Co., Ltd., NovelBio Bio-Pharm Technology Co., Ltd., OBiO Technology (Shanghai) Corp., Ltd. and Shanghai Jingzhou Gene Technology Co., Ltd. (Sinomics) represent China’s broad sequencing and life-science service base, where competition centers on platform access, sample-processing experience, bioinformatics and integrated project delivery. RIKEN GENESIS Co., Ltd. and Rhelixa, Inc. support the Japanese service market through genomics analysis and project execution. Competitive advantage depends on technology performance, installed workflow accessibility, reagent continuity, tissue-type coverage, data-analysis quality, application support and the capacity to convert complex assays into reproducible services.
Report Scope
LPI (LP Information)' newest research report, the “Spatial Transcriptomics Sequencing Industry Forecast” looks at past sales and reviews total world Spatial Transcriptomics Sequencing sales in 2025, providing a comprehensive analysis by region and market sector of projected Spatial Transcriptomics Sequencing sales for 2026 through 2032. With Spatial Transcriptomics Sequencing sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Spatial Transcriptomics Sequencing industry.
This Insight Report provides a comprehensive analysis of the global Spatial Transcriptomics Sequencing landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyses the strategies of leading global companies with a focus on Spatial Transcriptomics Sequencing portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Spatial Transcriptomics Sequencing market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Spatial Transcriptomics Sequencing and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Spatial Transcriptomics Sequencing.
This report presents a comprehensive overview, market shares, and growth opportunities of Spatial Transcriptomics Sequencing market by product type, application, key players and key regions and countries.
Market Segmentation
Spatial transcriptomics sequencing is an advanced molecular biology technique that combines the principles of transcriptomics (the study of the complete set of RNA transcripts in a cell or tissue) with spatial information. It enables the simultaneous measurement of gene expression levels and the determination of the location of those transcripts within a tissue sample. By preserving the spatial context of gene expression, this technology provides a more comprehensive understanding of how genes are expressed in different regions of a tissue, which is crucial for elucidating complex biological processes, disease mechanisms, and cellular interactions. It typically involves methods to capture and sequence RNA molecules directly from specific locations within a tissue section, followed by computational analysis to map the gene expression data back to their spatial coordinates.
Key Findings
Spatial Transcriptomics Sequencing links gene-expression measurements with native tissue architecture and cellular location
NGS-Based Capture Spatial Transcriptomics supports broad transcriptome profiling across spatially barcoded tissue areas
In Situ Sequencing-Based Spatial Transcriptomics emphasizes single-cell or subcellular localization and high-plex molecular imaging
Cancer Research Developmental Biology and Neuroscience form the principal application framework of the market
Market Trends
Spatial Transcriptomics Sequencing is progressing toward higher spatial resolution, broader transcript coverage, larger tissue capture areas and more integrated multiomic analysis. Sequencing-based systems are narrowing the historical trade-off between whole-transcriptome breadth and cellular-level localization through denser spatial features, improved barcoding chemistry and scalable sequencing workflows. In situ platforms are simultaneously increasing gene-panel size, imaging area, acquisition speed and compatibility with RNA and protein measurements in the same tissue section. Support for formalin-fixed paraffin-embedded samples is becoming increasingly important because it enables researchers to access archived clinical specimens and connect spatial information with established histopathology. The workflow is also shifting from instrument- or assay-centered purchasing toward complete sample-to-insight solutions combining tissue handling, reagents, sequencing or imaging, data processing, cell segmentation, visualization and biological interpretation. As datasets become larger, computational efficiency, interoperability and standardized quality-control metrics are becoming as important as molecular sensitivity. Longer term, the industry is moving toward reproducible cohort-scale studies, spatial multiomics, three-dimensional tissue reconstruction and closer integration with single-cell sequencing, digital pathology and artificial intelligence-assisted image analysis.
Market Dynamics
Drivers
The principal driver of Spatial Transcriptomics Sequencing is the need to understand biological heterogeneity without losing tissue context. Conventional bulk RNA sequencing averages signals across many cells, while dissociative single-cell methods provide cell-level expression profiles but separate cells from their original locations. Spatial workflows connect molecular states with tumor regions, neural structures, developmental compartments and neighboring cell populations, supporting more detailed analysis of cell interactions and tissue organization. Cancer researchers use the technology to investigate tumor microenvironments, immune-cell distribution, clonal organization and treatment-related changes. Developmental Biology studies use spatial maps to examine organ formation, cell-fate transitions and temporal patterning, while Neuroscience applications benefit from the ability to associate molecularly defined cell types with anatomical regions and neural circuits. Continued investment in genomics, precision medicine, biomarker research and tissue-atlas programs therefore expands the potential customer base across universities, medical centers, pharmaceutical companies and biotechnology developers.
Restraints
Spatial Transcriptomics Sequencing remains technically and economically demanding because results are highly sensitive to tissue quality, sectioning, fixation, permeabilization, staining, probe performance and experimental design. Some workflows require expensive dedicated instruments, proprietary consumables and high-capacity sequencing or imaging infrastructure, limiting adoption by laboratories with irregular sample volumes. Whole-transcriptome assays can generate substantial sequencing, storage and computational requirements, whereas targeted in situ methods require prior selection of genes and may miss unexpected biological signals outside the panel. Differences in spatial resolution, capture efficiency, tissue area, transcript sensitivity and cell-segmentation methodology also make direct comparison among platforms difficult. Sample preparation protocols may need optimization for different organs, species and preservation methods, and unsuccessful tissue processing can result in the loss of scarce clinical material. These factors increase the importance of experienced laboratory personnel and often encourage smaller research groups to outsource projects rather than establish complete internal workflows.
Opportunities
Major opportunities are developing around archived clinical tissue, spatial multiomics, large-cohort research and specialized sequencing services. Greater compatibility with formalin-fixed paraffin-embedded samples can unlock extensive pathology archives for retrospective Cancer Research and translational biomarker programs. Combining spatial RNA measurements with proteins, morphology, genomic alterations or other molecular layers can provide a more complete representation of cell states and tissue interactions than transcript analysis alone. Service providers can expand demand by offering integrated tissue assessment, experimental design, sectioning, staining, assay execution, sequencing, imaging, bioinformatics and biological interpretation, thereby lowering technical barriers for laboratories without dedicated spatial infrastructure. New opportunities also arise from cross-species studies, organoids, regenerative biology, drug-response mapping and preclinical model characterization. Suppliers capable of improving throughput and workflow standardization may support a transition from small exploratory experiments to larger cohort studies and pharmaceutical research programs.
Challenges
The industry must address reproducibility, analytical standardization and biological interpretation as Spatial Transcriptomics Sequencing moves into larger and more decision-relevant studies. Tissue morphology, RNA integrity, capture chemistry, imaging quality, sequencing depth and computational parameters can each influence the final spatial map. Cell segmentation is particularly important for cellular and subcellular workflows because incorrect boundaries can assign transcripts to the wrong cell and distort cell-type or interaction analysis. Batch effects arising from different slides, instruments, laboratories or sample-processing dates can complicate multi-center studies. The lack of universally accepted metrics for comparing sensitivity, effective resolution, transcript recovery and usable tissue area also creates uncertainty for customers evaluating competing technologies. Researchers must additionally manage very large image and molecular datasets while maintaining traceability from raw data to interpreted results. Translation into clinical decision-making will require stronger validation, reproducible operating procedures and evidence that spatial biomarkers provide value beyond conventional pathology and sequencing approaches.
Industry Chain Analysis
The upstream portion of the Spatial Transcriptomics Sequencing industry chain comprises tissue slides and capture substrates, spatial barcodes, oligonucleotide probes, enzymes, antibodies, staining reagents, library-preparation materials, sequencing consumables, imaging components and laboratory automation equipment. It also includes sequencers, high-resolution microscopes, fluidic systems, scanners, servers, cloud-computing resources and software infrastructure. Upstream performance directly influences RNA recovery, optical quality, spatial fidelity, assay reproducibility and usable tissue area. Sample-specific requirements create close interaction among reagent developers, instrument manufacturers, pathology laboratories and sequencing technology providers.
The midstream segment includes spatial platform developers, sequencing-system suppliers and specialized service laboratories that convert tissue samples into spatially resolved expression datasets. Their activities cover sample acceptance, pathology review, tissue optimization, molecular processing, library construction, sequencing or imaging, primary data processing, cell segmentation, spatial clustering and visualization. Downstream users include universities, research institutes, hospitals, pharmaceutical companies, biotechnology enterprises and contract research organizations. Value creation is concentrated in robust sample preparation, dependable molecular sensitivity, resolution, throughput, bioinformatics capability and accurate biological interpretation. Major costs include proprietary reagents, tissue processing, instrument depreciation, sequencing, image acquisition, data storage, computation and specialist labor. Platform suppliers generate value through instruments, consumables and software, while service providers compete through workflow breadth, project experience, turnaround time and analytical support.
Segment Insights
NGS-Based Capture Spatial Transcriptomics is positioned around broad gene-expression discovery and generally integrates tissue imaging with spatially indexed RNA capture, library preparation and next-generation sequencing. Its principal advantage is the ability to profile a large portion of the transcriptome without restricting the experiment to a narrowly predefined gene panel. Denser capture arrays and improved computational binning are enabling increasingly detailed analysis approaching cellular scale, while high-throughput sequencers support expansion into larger tissue areas and sample cohorts. The segment is particularly suitable for discovery research, tissue atlasing and projects in which unexpected pathways or cell states may be important. Its operational requirements include sequencing capacity, substantial data processing and careful coordination between histology and molecular workflows.
In Situ Sequencing-Based Spatial Transcriptomics and related imaging-based approaches measure transcripts within intact tissue through multiplexed cycles of hybridization, imaging or local molecular identification. These technologies provide strong single-cell and subcellular localization, allowing researchers to examine cell boundaries, intracellular transcript distribution and interactions between neighboring cell populations. Targeted panels can offer high sensitivity for selected genes and efficient hypothesis-driven studies, while newer systems are expanding toward substantially broader transcript coverage. The Others segment includes region-of-interest profiling, alternative bead- or array-based capture methods and specialized workflows combining spatial transcriptomics with other molecular measurements. The competitive boundary among segments is becoming less rigid as sequencing-based products improve resolution and imaging-based systems expand gene coverage and tissue throughput.
Downstream Market Opportunities
Cancer Research provides a major downstream opportunity because Spatial Transcriptomics Sequencing can distinguish tumor, stromal and immune compartments while preserving their physical relationships. This supports investigation of intratumoral heterogeneity, immune exclusion, metastatic niches, drug-response mechanisms and candidate spatial biomarkers. Developmental Biology benefits from the ability to reconstruct where cell states emerge and how organs are organized over time, creating opportunities in embryology, regenerative research, organoids and comparative biology. Neuroscience applications use spatial expression maps to classify cell populations across brain regions, connect molecular identity with anatomy and investigate neurological disease. The Other category includes immunology, infectious diseases, cardiovascular research, metabolic disease, fibrosis, tissue engineering and pharmaceutical development. Across these applications, the strongest commercial opportunities arise when technology providers and service laboratories can support complex sample types, provide reliable pathology integration and convert high-dimensional spatial data into interpretable biological conclusions.
Regional Insights
North America represents the most mature commercialization ecosystem for Spatial Transcriptomics Sequencing, supported by a concentration of platform developers, sequencing technology companies, biomedical research institutions, pharmaceutical enterprises and specialist service providers. The region has broad adoption across Cancer Research, translational medicine and neuroscience, and customers can access both instrument-based workflows and outsourced end-to-end services. Continued product launches in sequencing-based and imaging-based spatial systems are expanding competition across resolution, transcript coverage, sample compatibility and analytical software. Europe also has significant capabilities in molecular imaging, in situ analysis, pathology research and pharmaceutical development, with regional demand shaped by academic research networks and translational projects using preserved clinical tissue.
Asia-Pacific has become an important innovation and service-delivery region. China combines domestic spatial technology development with an extensive genomics-service infrastructure, while Japan has established sequencing, biomedical research and clinical-sample processing capabilities. Regional suppliers increasingly offer multiple technical routes rather than a single assay, allowing customers to select workflows according to tissue type, resolution, transcript coverage and research budget. Large population cohorts, active cancer and neuroscience research, and expanding pharmaceutical research create a foundation for future demand. However, adoption varies by country because advanced instruments, specialist pathology resources, computational capacity and research funding remain unevenly distributed.
Competitive Landscape Analysis
The Spatial Transcriptomics Sequencing market has a layered competitive structure comprising platform developers, sequencing infrastructure providers and outsourced multiomics service companies. 10x Genomics, Inc. has established a strong position in NGS-Based Capture Spatial Transcriptomics through its spatially barcoded whole-transcriptome workflows, while Bruker Spatial Biology and Vizgen, Inc. compete in high-plex imaging and cellular or subcellular spatial analysis. Illumina, Inc. is extending its sequencing ecosystem into an end-to-end spatial solution, increasing competition around whole-transcriptome breadth, spatial resolution and workflow scalability. STOmics (BGI Spatial), Resolve Biosciences GmbH and Curio Bioscience, Inc. provide differentiated spatial architectures based on large-area capture, in situ molecular mapping or sequencing-compatible spatial arrays. Takara Bio Inc. participates through its broader molecular biology and sequencing workflow capabilities. Novogene Co., Ltd., Biomarker Technologies Corporation, LC-Bio Technology Co., Ltd., Majorbio Bio-Pharm Technology Co., Ltd., Shanghai Biotechnology Corporation, Annoroad Gene Technology (Beijing) Co., Ltd., OE Biotech Co., Ltd., NovelBio Bio-Pharm Technology Co., Ltd., OBiO Technology (Shanghai) Corp., Ltd. and Shanghai Jingzhou Gene Technology Co., Ltd. (Sinomics) represent China’s broad sequencing and life-science service base, where competition centers on platform access, sample-processing experience, bioinformatics and integrated project delivery. RIKEN GENESIS Co., Ltd. and Rhelixa, Inc. support the Japanese service market through genomics analysis and project execution. Competitive advantage depends on technology performance, installed workflow accessibility, reagent continuity, tissue-type coverage, data-analysis quality, application support and the capacity to convert complex assays into reproducible services.
Report Scope
LPI (LP Information)' newest research report, the “Spatial Transcriptomics Sequencing Industry Forecast” looks at past sales and reviews total world Spatial Transcriptomics Sequencing sales in 2025, providing a comprehensive analysis by region and market sector of projected Spatial Transcriptomics Sequencing sales for 2026 through 2032. With Spatial Transcriptomics Sequencing sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Spatial Transcriptomics Sequencing industry.
This Insight Report provides a comprehensive analysis of the global Spatial Transcriptomics Sequencing landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyses the strategies of leading global companies with a focus on Spatial Transcriptomics Sequencing portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Spatial Transcriptomics Sequencing market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Spatial Transcriptomics Sequencing and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Spatial Transcriptomics Sequencing.
This report presents a comprehensive overview, market shares, and growth opportunities of Spatial Transcriptomics Sequencing market by product type, application, key players and key regions and countries.
Market Segmentation
Segmentation by Type:
- NGS-Based Capture Spatial Transcriptomics
- In Situ Sequencing-Based Spatial Transcriptomics
- Others
Segmentation by Transcript Coverage:
- Whole-Transcriptome Spatial Profiling
- Targeted High-Plex Spatial Profiling
- Custom Gene-Panel Spatial Profiling
Segmentation by Spatial Spot Diameter:
- Low Resolution Platform: Spot Diameter > 100 ?m
- Medium Resolution Platform: Spot Diameter 10 ?m – 100 ?m
- Single-Cell High Resolution Platform: Spot Diameter < 10 ?m
Segmentation by Application:
- Cancer Research
- Developmental Biology
- Neuroscience
- Other
This report also splits the market by region:
- Americas
- United States
- Canada
- Mexico
- Brazil
- APAC
- China
- Japan
- Korea
- Southeast Asia
- India
- Australia
- Europe
- Germany
- France
- UK
- Italy
- Russia
- Middle East & Africa
- Egypt
- South Africa
- Israel
- Turkey
- GCC Countries
- 10x Genomics, Inc.
- Bruker Spatial Biology
- Illumina, Inc.
- Novogene Co., Ltd.
- STOmics (BGI Spatial)
- Vizgen, Inc.
- Takara Bio Inc.
- Biomarker Technologies Corporation
- LC-Bio Technology Co., Ltd.
- Majorbio Bio-Pharm Technology Co., Ltd.
- Shanghai Biotechnology Corporation
- Resolve Biosciences GmbH
- Curio Bioscience, Inc.
- Annoroad Gene Technology (Beijing) Co., Ltd.
- OE Biotech Co., Ltd.
- NovelBio Bio-Pharm Technology Co., Ltd.
- OBiO Technology (Shanghai) Corp., Ltd.
- Shanghai Jingzhou Gene Technology Co., Ltd. (Sinomics)
- RIKEN GENESIS Co., Ltd.
- Rhelixa, Inc.
1 SCOPE OF THE REPORT
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Spatial Transcriptomics Sequencing Market Size (2021-2032)
2.1.2 Spatial Transcriptomics Sequencing Market Size CAGR by Region (2021 VS 2025 VS 2032)
2.1.3 World Current & Future Analysis for Spatial Transcriptomics Sequencing by Country/Region (2021, 2025 & 2032)
2.2 Spatial Transcriptomics Sequencing Segment by Type
2.2.1 NGS-Based Capture Spatial Transcriptomics
2.2.2 In Situ Sequencing-Based Spatial Transcriptomics
2.2.3 Others
2.2.4 Spatial Transcriptomics Sequencing Market Size by Type
2.2.4.1 Spatial Transcriptomics Sequencing Market Size CAGR by Type (2021 VS 2025 VS 2032)
2.2.4.2 Global Spatial Transcriptomics Sequencing Market Size Market Share by Type (2021-2026)
2.3 Spatial Transcriptomics Sequencing Segment by Transcript Coverage
2.3.1 Whole-Transcriptome Spatial Profiling
2.3.2 Targeted High-Plex Spatial Profiling
2.3.3 Custom Gene-Panel Spatial Profiling
2.3.4 Spatial Transcriptomics Sequencing Market Size by Transcript Coverage
2.3.4.1 Spatial Transcriptomics Sequencing Market Size CAGR by Transcript Coverage (2021 VS 2025 VS 2032)
2.3.4.2 Global Spatial Transcriptomics Sequencing Market Size Market Share by Transcript Coverage (2021-2026)
2.4 Spatial Transcriptomics Sequencing Segment by Spatial Spot Diameter
2.4.1 Low Resolution Platform: Spot Diameter > 100 ?m
2.4.2 Medium Resolution Platform: Spot Diameter 10 ?m – 100 ?m
2.4.3 Single-Cell High Resolution Platform: Spot Diameter < 10 ?m
2.4.4 Spatial Transcriptomics Sequencing Market Size by Spatial Spot Diameter
2.4.4.1 Spatial Transcriptomics Sequencing Market Size CAGR by Spatial Spot Diameter (2021 VS 2025 VS 2032)
2.4.4.2 Global Spatial Transcriptomics Sequencing Market Size Market Share by Spatial Spot Diameter (2021-2026)
2.5 Spatial Transcriptomics Sequencing Segment by Application
2.5.1 Cancer Research
2.5.2 Developmental Biology
2.5.3 Neuroscience
2.5.4 Other
2.5.5 Spatial Transcriptomics Sequencing Market Size by Application
2.5.5.1 Spatial Transcriptomics Sequencing Market Size CAGR by Application (2021 VS 2025 VS 2032)
2.5.5.2 Global Spatial Transcriptomics Sequencing Market Size Market Share by Application (2021-2026)
3 SPATIAL TRANSCRIPTOMICS SEQUENCING MARKET SIZE BY PLAYER
3.1 Spatial Transcriptomics Sequencing Market Size Market Share by Player
3.1.1 Global Spatial Transcriptomics Sequencing Revenue by Player (2021-2026)
3.1.2 Global Spatial Transcriptomics Sequencing Revenue Market Share by Player (2021-2026)
3.2 Global Spatial Transcriptomics Sequencing Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
3.3.1 Competition Landscape Analysis
3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2024-2026)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion
4 SPATIAL TRANSCRIPTOMICS SEQUENCING BY REGION
4.1 Spatial Transcriptomics Sequencing Market Size by Region (2021-2026)
4.2 Global Spatial Transcriptomics Sequencing Annual Revenue by Country/Region (2021-2026)
4.3 Americas Spatial Transcriptomics Sequencing Market Size Growth (2021-2026)
4.4 APAC Spatial Transcriptomics Sequencing Market Size Growth (2021-2026)
4.5 Europe Spatial Transcriptomics Sequencing Market Size Growth (2021-2026)
4.6 Middle East & Africa Spatial Transcriptomics Sequencing Market Size Growth (2021-2026)
5 AMERICAS
5.1 Americas Spatial Transcriptomics Sequencing Market Size by Country (2021-2026)
5.2 Americas Spatial Transcriptomics Sequencing Market Size by Type (2021-2026)
5.3 Americas Spatial Transcriptomics Sequencing Market Size by Application (2021-2026)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Spatial Transcriptomics Sequencing Market Size by Region (2021-2026)
6.2 APAC Spatial Transcriptomics Sequencing Market Size by Type (2021-2026)
6.3 APAC Spatial Transcriptomics Sequencing Market Size by Application (2021-2026)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
7 EUROPE
7.1 Europe Spatial Transcriptomics Sequencing Market Size by Country (2021-2026)
7.2 Europe Spatial Transcriptomics Sequencing Market Size by Type (2021-2026)
7.3 Europe Spatial Transcriptomics Sequencing Market Size by Application (2021-2026)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Spatial Transcriptomics Sequencing by Region (2021-2026)
8.2 Middle East & Africa Spatial Transcriptomics Sequencing Market Size by Type (2021-2026)
8.3 Middle East & Africa Spatial Transcriptomics Sequencing Market Size by Application (2021-2026)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 GLOBAL SPATIAL TRANSCRIPTOMICS SEQUENCING MARKET FORECAST
10.1 Global Spatial Transcriptomics Sequencing Forecast by Region (2027-2032)
10.1.1 Global Spatial Transcriptomics Sequencing Forecast by Region (2027-2032)
10.1.2 Americas Spatial Transcriptomics Sequencing Forecast
10.1.3 APAC Spatial Transcriptomics Sequencing Forecast
10.1.4 Europe Spatial Transcriptomics Sequencing Forecast
10.1.5 Middle East & Africa Spatial Transcriptomics Sequencing Forecast
10.2 Americas Spatial Transcriptomics Sequencing Forecast by Country (2027-2032)
10.2.1 United States Market Spatial Transcriptomics Sequencing Forecast
10.2.2 Canada Market Spatial Transcriptomics Sequencing Forecast
10.2.3 Mexico Market Spatial Transcriptomics Sequencing Forecast
10.2.4 Brazil Market Spatial Transcriptomics Sequencing Forecast
10.3 APAC Spatial Transcriptomics Sequencing Forecast by Region (2027-2032)
10.3.1 China Spatial Transcriptomics Sequencing Market Forecast
10.3.2 Japan Market Spatial Transcriptomics Sequencing Forecast
10.3.3 Korea Market Spatial Transcriptomics Sequencing Forecast
10.3.4 Southeast Asia Market Spatial Transcriptomics Sequencing Forecast
10.3.5 India Market Spatial Transcriptomics Sequencing Forecast
10.3.6 Australia Market Spatial Transcriptomics Sequencing Forecast
10.4 Europe Spatial Transcriptomics Sequencing Forecast by Country (2027-2032)
10.4.1 Germany Market Spatial Transcriptomics Sequencing Forecast
10.4.2 France Market Spatial Transcriptomics Sequencing Forecast
10.4.3 UK Market Spatial Transcriptomics Sequencing Forecast
10.4.4 Italy Market Spatial Transcriptomics Sequencing Forecast
10.4.5 Russia Market Spatial Transcriptomics Sequencing Forecast
10.5 Middle East & Africa Spatial Transcriptomics Sequencing Forecast by Region (2027-2032)
10.5.1 Egypt Market Spatial Transcriptomics Sequencing Forecast
10.5.2 South Africa Market Spatial Transcriptomics Sequencing Forecast
10.5.3 Israel Market Spatial Transcriptomics Sequencing Forecast
10.5.4 Turkey Market Spatial Transcriptomics Sequencing Forecast
10.6 Global Spatial Transcriptomics Sequencing Forecast by Type (2027-2032)
10.7 Global Spatial Transcriptomics Sequencing Forecast by Application (2027-2032)
10.7.1 GCC Countries Market Spatial Transcriptomics Sequencing Forecast
11 KEY PLAYERS ANALYSIS
11.1 10x Genomics, Inc.
11.1.1 10x Genomics, Inc. Company Information
11.1.2 10x Genomics, Inc. Spatial Transcriptomics Sequencing Product Offered
11.1.3 10x Genomics, Inc. Spatial Transcriptomics Sequencing Revenue, Gross Margin and Market Share (2021-2026)
11.1.4 10x Genomics, Inc. Main Business Overview
11.1.5 10x Genomics, Inc. Latest Developments
11.2 Bruker Spatial Biology
11.2.1 Bruker Spatial Biology Company Information
11.2.2 Bruker Spatial Biology Spatial Transcriptomics Sequencing Product Offered
11.2.3 Bruker Spatial Biology Spatial Transcriptomics Sequencing Revenue, Gross Margin and Market Share (2021-2026)
11.2.4 Bruker Spatial Biology Main Business Overview
11.2.5 Bruker Spatial Biology Latest Developments
11.3 Illumina, Inc.
11.3.1 Illumina, Inc. Company Information
11.3.2 Illumina, Inc. Spatial Transcriptomics Sequencing Product Offered
11.3.3 Illumina, Inc. Spatial Transcriptomics Sequencing Revenue, Gross Margin and Market Share (2021-2026)
11.3.4 Illumina, Inc. Main Business Overview
11.3.5 Illumina, Inc. Latest Developments
11.4 Novogene Co., Ltd.
11.4.1 Novogene Co., Ltd. Company Information
11.4.2 Novogene Co., Ltd. Spatial Transcriptomics Sequencing Product Offered
11.4.3 Novogene Co., Ltd. Spatial Transcriptomics Sequencing Revenue, Gross Margin and Market Share (2021-2026)
11.4.4 Novogene Co., Ltd. Main Business Overview
11.4.5 Novogene Co., Ltd. Latest Developments
11.5 STOmics (BGI Spatial)
11.5.1 STOmics (BGI Spatial) Company Information
11.5.2 STOmics (BGI Spatial) Spatial Transcriptomics Sequencing Product Offered
11.5.3 STOmics (BGI Spatial) Spatial Transcriptomics Sequencing Revenue, Gross Margin and Market Share (2021-2026)
11.5.4 STOmics (BGI Spatial) Main Business Overview
11.5.5 STOmics (BGI Spatial) Latest Developments
11.6 Vizgen, Inc.
11.6.1 Vizgen, Inc. Company Information
11.6.2 Vizgen, Inc. Spatial Transcriptomics Sequencing Product Offered
11.6.3 Vizgen, Inc. Spatial Transcriptomics Sequencing Revenue, Gross Margin and Market Share (2021-2026)
11.6.4 Vizgen, Inc. Main Business Overview
11.6.5 Vizgen, Inc. Latest Developments
11.7 Takara Bio Inc.
11.7.1 Takara Bio Inc. Company Information
11.7.2 Takara Bio Inc. Spatial Transcriptomics Sequencing Product Offered
11.7.3 Takara Bio Inc. Spatial Transcriptomics Sequencing Revenue, Gross Margin and Market Share (2021-2026)
11.7.4 Takara Bio Inc. Main Business Overview
11.7.5 Takara Bio Inc. Latest Developments
11.8 Biomarker Technologies Corporation
11.8.1 Biomarker Technologies Corporation Company Information
11.8.2 Biomarker Technologies Corporation Spatial Transcriptomics Sequencing Product Offered
11.8.3 Biomarker Technologies Corporation Spatial Transcriptomics Sequencing Revenue, Gross Margin and Market Share (2021-2026)
11.8.4 Biomarker Technologies Corporation Main Business Overview
11.8.5 Biomarker Technologies Corporation Latest Developments
11.9 LC-Bio Technology Co., Ltd.
11.9.1 LC-Bio Technology Co., Ltd. Company Information
11.9.2 LC-Bio Technology Co., Ltd. Spatial Transcriptomics Sequencing Product Offered
11.9.3 LC-Bio Technology Co., Ltd. Spatial Transcriptomics Sequencing Revenue, Gross Margin and Market Share (2021-2026)
11.9.4 LC-Bio Technology Co., Ltd. Main Business Overview
11.9.5 LC-Bio Technology Co., Ltd. Latest Developments
11.10 Majorbio Bio-Pharm Technology Co., Ltd.
11.10.1 Majorbio Bio-Pharm Technology Co., Ltd. Company Information
11.10.2 Majorbio Bio-Pharm Technology Co., Ltd. Spatial Transcriptomics Sequencing Product Offered
11.10.3 Majorbio Bio-Pharm Technology Co., Ltd. Spatial Transcriptomics Sequencing Revenue, Gross Margin and Market Share (2021-2026)
11.10.4 Majorbio Bio-Pharm Technology Co., Ltd. Main Business Overview
11.10.5 Majorbio Bio-Pharm Technology Co., Ltd. Latest Developments
11.11 Shanghai Biotechnology Corporation
11.11.1 Shanghai Biotechnology Corporation Company Information
11.11.2 Shanghai Biotechnology Corporation Spatial Transcriptomics Sequencing Product Offered
11.11.3 Shanghai Biotechnology Corporation Spatial Transcriptomics Sequencing Revenue, Gross Margin and Market Share (2021-2026)
11.11.4 Shanghai Biotechnology Corporation Main Business Overview
11.11.5 Shanghai Biotechnology Corporation Latest Developments
11.12 Resolve Biosciences GmbH
11.12.1 Resolve Biosciences GmbH Company Information
11.12.2 Resolve Biosciences GmbH Spatial Transcriptomics Sequencing Product Offered
11.12.3 Resolve Biosciences GmbH Spatial Transcriptomics Sequencing Revenue, Gross Margin and Market Share (2021-2026)
11.12.4 Resolve Biosciences GmbH Main Business Overview
11.12.5 Resolve Biosciences GmbH Latest Developments
11.13 Curio Bioscience, Inc.
11.13.1 Curio Bioscience, Inc. Company Information
11.13.2 Curio Bioscience, Inc. Spatial Transcriptomics Sequencing Product Offered
11.13.3 Curio Bioscience, Inc. Spatial Transcriptomics Sequencing Revenue, Gross Margin and Market Share (2021-2026)
11.13.4 Curio Bioscience, Inc. Main Business Overview
11.13.5 Curio Bioscience, Inc. Latest Developments
11.14 Annoroad Gene Technology (Beijing) Co., Ltd.
11.14.1 Annoroad Gene Technology (Beijing) Co., Ltd. Company Information
11.14.2 Annoroad Gene Technology (Beijing) Co., Ltd. Spatial Transcriptomics Sequencing Product Offered
11.14.3 Annoroad Gene Technology (Beijing) Co., Ltd. Spatial Transcriptomics Sequencing Revenue, Gross Margin and Market Share (2021-2026)
11.14.4 Annoroad Gene Technology (Beijing) Co., Ltd. Main Business Overview
11.14.5 Annoroad Gene Technology (Beijing) Co., Ltd. Latest Developments
11.15 OE Biotech Co., Ltd.
11.15.1 OE Biotech Co., Ltd. Company Information
11.15.2 OE Biotech Co., Ltd. Spatial Transcriptomics Sequencing Product Offered
11.15.3 OE Biotech Co., Ltd. Spatial Transcriptomics Sequencing Revenue, Gross Margin and Market Share (2021-2026)
11.15.4 OE Biotech Co., Ltd. Main Business Overview
11.15.5 OE Biotech Co., Ltd. Latest Developments
11.16 NovelBio Bio-Pharm Technology Co., Ltd.
11.16.1 NovelBio Bio-Pharm Technology Co., Ltd. Company Information
11.16.2 NovelBio Bio-Pharm Technology Co., Ltd. Spatial Transcriptomics Sequencing Product Offered
11.16.3 NovelBio Bio-Pharm Technology Co., Ltd. Spatial Transcriptomics Sequencing Revenue, Gross Margin and Market Share (2021-2026)
11.16.4 NovelBio Bio-Pharm Technology Co., Ltd. Main Business Overview
11.16.5 NovelBio Bio-Pharm Technology Co., Ltd. Latest Developments
11.17 OBiO Technology (Shanghai) Corp., Ltd.
11.17.1 OBiO Technology (Shanghai) Corp., Ltd. Company Information
11.17.2 OBiO Technology (Shanghai) Corp., Ltd. Spatial Transcriptomics Sequencing Product Offered
11.17.3 OBiO Technology (Shanghai) Corp., Ltd. Spatial Transcriptomics Sequencing Revenue, Gross Margin and Market Share (2021-2026)
11.17.4 OBiO Technology (Shanghai) Corp., Ltd. Main Business Overview
11.17.5 OBiO Technology (Shanghai) Corp., Ltd. Latest Developments
11.18 Shanghai Jingzhou Gene Technology Co., Ltd. (Sinomics)
11.18.1 Shanghai Jingzhou Gene Technology Co., Ltd. (Sinomics) Company Information
11.18.2 Shanghai Jingzhou Gene Technology Co., Ltd. (Sinomics) Spatial Transcriptomics Sequencing Product Offered
11.18.3 Shanghai Jingzhou Gene Technology Co., Ltd. (Sinomics) Spatial Transcriptomics Sequencing Revenue, Gross Margin and Market Share (2021-2026)
11.18.4 Shanghai Jingzhou Gene Technology Co., Ltd. (Sinomics) Main Business Overview
11.18.5 Shanghai Jingzhou Gene Technology Co., Ltd. (Sinomics) Latest Developments
11.19 RIKEN GENESIS Co., Ltd.
11.19.1 RIKEN GENESIS Co., Ltd. Company Information
11.19.2 RIKEN GENESIS Co., Ltd. Spatial Transcriptomics Sequencing Product Offered
11.19.3 RIKEN GENESIS Co., Ltd. Spatial Transcriptomics Sequencing Revenue, Gross Margin and Market Share (2021-2026)
11.19.4 RIKEN GENESIS Co., Ltd. Main Business Overview
11.19.5 RIKEN GENESIS Co., Ltd. Latest Developments
11.20 Rhelixa, Inc.
11.20.1 Rhelixa, Inc. Company Information
11.20.2 Rhelixa, Inc. Spatial Transcriptomics Sequencing Product Offered
11.20.3 Rhelixa, Inc. Spatial Transcriptomics Sequencing Revenue, Gross Margin and Market Share (2021-2026)
11.20.4 Rhelixa, Inc. Main Business Overview
11.20.5 Rhelixa, Inc. Latest Developments
12 RESEARCH FINDINGS AND CONCLUSION
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Spatial Transcriptomics Sequencing Market Size (2021-2032)
2.1.2 Spatial Transcriptomics Sequencing Market Size CAGR by Region (2021 VS 2025 VS 2032)
2.1.3 World Current & Future Analysis for Spatial Transcriptomics Sequencing by Country/Region (2021, 2025 & 2032)
2.2 Spatial Transcriptomics Sequencing Segment by Type
2.2.1 NGS-Based Capture Spatial Transcriptomics
2.2.2 In Situ Sequencing-Based Spatial Transcriptomics
2.2.3 Others
2.2.4 Spatial Transcriptomics Sequencing Market Size by Type
2.2.4.1 Spatial Transcriptomics Sequencing Market Size CAGR by Type (2021 VS 2025 VS 2032)
2.2.4.2 Global Spatial Transcriptomics Sequencing Market Size Market Share by Type (2021-2026)
2.3 Spatial Transcriptomics Sequencing Segment by Transcript Coverage
2.3.1 Whole-Transcriptome Spatial Profiling
2.3.2 Targeted High-Plex Spatial Profiling
2.3.3 Custom Gene-Panel Spatial Profiling
2.3.4 Spatial Transcriptomics Sequencing Market Size by Transcript Coverage
2.3.4.1 Spatial Transcriptomics Sequencing Market Size CAGR by Transcript Coverage (2021 VS 2025 VS 2032)
2.3.4.2 Global Spatial Transcriptomics Sequencing Market Size Market Share by Transcript Coverage (2021-2026)
2.4 Spatial Transcriptomics Sequencing Segment by Spatial Spot Diameter
2.4.1 Low Resolution Platform: Spot Diameter > 100 ?m
2.4.2 Medium Resolution Platform: Spot Diameter 10 ?m – 100 ?m
2.4.3 Single-Cell High Resolution Platform: Spot Diameter < 10 ?m
2.4.4 Spatial Transcriptomics Sequencing Market Size by Spatial Spot Diameter
2.4.4.1 Spatial Transcriptomics Sequencing Market Size CAGR by Spatial Spot Diameter (2021 VS 2025 VS 2032)
2.4.4.2 Global Spatial Transcriptomics Sequencing Market Size Market Share by Spatial Spot Diameter (2021-2026)
2.5 Spatial Transcriptomics Sequencing Segment by Application
2.5.1 Cancer Research
2.5.2 Developmental Biology
2.5.3 Neuroscience
2.5.4 Other
2.5.5 Spatial Transcriptomics Sequencing Market Size by Application
2.5.5.1 Spatial Transcriptomics Sequencing Market Size CAGR by Application (2021 VS 2025 VS 2032)
2.5.5.2 Global Spatial Transcriptomics Sequencing Market Size Market Share by Application (2021-2026)
3 SPATIAL TRANSCRIPTOMICS SEQUENCING MARKET SIZE BY PLAYER
3.1 Spatial Transcriptomics Sequencing Market Size Market Share by Player
3.1.1 Global Spatial Transcriptomics Sequencing Revenue by Player (2021-2026)
3.1.2 Global Spatial Transcriptomics Sequencing Revenue Market Share by Player (2021-2026)
3.2 Global Spatial Transcriptomics Sequencing Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
3.3.1 Competition Landscape Analysis
3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2024-2026)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion
4 SPATIAL TRANSCRIPTOMICS SEQUENCING BY REGION
4.1 Spatial Transcriptomics Sequencing Market Size by Region (2021-2026)
4.2 Global Spatial Transcriptomics Sequencing Annual Revenue by Country/Region (2021-2026)
4.3 Americas Spatial Transcriptomics Sequencing Market Size Growth (2021-2026)
4.4 APAC Spatial Transcriptomics Sequencing Market Size Growth (2021-2026)
4.5 Europe Spatial Transcriptomics Sequencing Market Size Growth (2021-2026)
4.6 Middle East & Africa Spatial Transcriptomics Sequencing Market Size Growth (2021-2026)
5 AMERICAS
5.1 Americas Spatial Transcriptomics Sequencing Market Size by Country (2021-2026)
5.2 Americas Spatial Transcriptomics Sequencing Market Size by Type (2021-2026)
5.3 Americas Spatial Transcriptomics Sequencing Market Size by Application (2021-2026)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Spatial Transcriptomics Sequencing Market Size by Region (2021-2026)
6.2 APAC Spatial Transcriptomics Sequencing Market Size by Type (2021-2026)
6.3 APAC Spatial Transcriptomics Sequencing Market Size by Application (2021-2026)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
7 EUROPE
7.1 Europe Spatial Transcriptomics Sequencing Market Size by Country (2021-2026)
7.2 Europe Spatial Transcriptomics Sequencing Market Size by Type (2021-2026)
7.3 Europe Spatial Transcriptomics Sequencing Market Size by Application (2021-2026)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Spatial Transcriptomics Sequencing by Region (2021-2026)
8.2 Middle East & Africa Spatial Transcriptomics Sequencing Market Size by Type (2021-2026)
8.3 Middle East & Africa Spatial Transcriptomics Sequencing Market Size by Application (2021-2026)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 GLOBAL SPATIAL TRANSCRIPTOMICS SEQUENCING MARKET FORECAST
10.1 Global Spatial Transcriptomics Sequencing Forecast by Region (2027-2032)
10.1.1 Global Spatial Transcriptomics Sequencing Forecast by Region (2027-2032)
10.1.2 Americas Spatial Transcriptomics Sequencing Forecast
10.1.3 APAC Spatial Transcriptomics Sequencing Forecast
10.1.4 Europe Spatial Transcriptomics Sequencing Forecast
10.1.5 Middle East & Africa Spatial Transcriptomics Sequencing Forecast
10.2 Americas Spatial Transcriptomics Sequencing Forecast by Country (2027-2032)
10.2.1 United States Market Spatial Transcriptomics Sequencing Forecast
10.2.2 Canada Market Spatial Transcriptomics Sequencing Forecast
10.2.3 Mexico Market Spatial Transcriptomics Sequencing Forecast
10.2.4 Brazil Market Spatial Transcriptomics Sequencing Forecast
10.3 APAC Spatial Transcriptomics Sequencing Forecast by Region (2027-2032)
10.3.1 China Spatial Transcriptomics Sequencing Market Forecast
10.3.2 Japan Market Spatial Transcriptomics Sequencing Forecast
10.3.3 Korea Market Spatial Transcriptomics Sequencing Forecast
10.3.4 Southeast Asia Market Spatial Transcriptomics Sequencing Forecast
10.3.5 India Market Spatial Transcriptomics Sequencing Forecast
10.3.6 Australia Market Spatial Transcriptomics Sequencing Forecast
10.4 Europe Spatial Transcriptomics Sequencing Forecast by Country (2027-2032)
10.4.1 Germany Market Spatial Transcriptomics Sequencing Forecast
10.4.2 France Market Spatial Transcriptomics Sequencing Forecast
10.4.3 UK Market Spatial Transcriptomics Sequencing Forecast
10.4.4 Italy Market Spatial Transcriptomics Sequencing Forecast
10.4.5 Russia Market Spatial Transcriptomics Sequencing Forecast
10.5 Middle East & Africa Spatial Transcriptomics Sequencing Forecast by Region (2027-2032)
10.5.1 Egypt Market Spatial Transcriptomics Sequencing Forecast
10.5.2 South Africa Market Spatial Transcriptomics Sequencing Forecast
10.5.3 Israel Market Spatial Transcriptomics Sequencing Forecast
10.5.4 Turkey Market Spatial Transcriptomics Sequencing Forecast
10.6 Global Spatial Transcriptomics Sequencing Forecast by Type (2027-2032)
10.7 Global Spatial Transcriptomics Sequencing Forecast by Application (2027-2032)
10.7.1 GCC Countries Market Spatial Transcriptomics Sequencing Forecast
11 KEY PLAYERS ANALYSIS
11.1 10x Genomics, Inc.
11.1.1 10x Genomics, Inc. Company Information
11.1.2 10x Genomics, Inc. Spatial Transcriptomics Sequencing Product Offered
11.1.3 10x Genomics, Inc. Spatial Transcriptomics Sequencing Revenue, Gross Margin and Market Share (2021-2026)
11.1.4 10x Genomics, Inc. Main Business Overview
11.1.5 10x Genomics, Inc. Latest Developments
11.2 Bruker Spatial Biology
11.2.1 Bruker Spatial Biology Company Information
11.2.2 Bruker Spatial Biology Spatial Transcriptomics Sequencing Product Offered
11.2.3 Bruker Spatial Biology Spatial Transcriptomics Sequencing Revenue, Gross Margin and Market Share (2021-2026)
11.2.4 Bruker Spatial Biology Main Business Overview
11.2.5 Bruker Spatial Biology Latest Developments
11.3 Illumina, Inc.
11.3.1 Illumina, Inc. Company Information
11.3.2 Illumina, Inc. Spatial Transcriptomics Sequencing Product Offered
11.3.3 Illumina, Inc. Spatial Transcriptomics Sequencing Revenue, Gross Margin and Market Share (2021-2026)
11.3.4 Illumina, Inc. Main Business Overview
11.3.5 Illumina, Inc. Latest Developments
11.4 Novogene Co., Ltd.
11.4.1 Novogene Co., Ltd. Company Information
11.4.2 Novogene Co., Ltd. Spatial Transcriptomics Sequencing Product Offered
11.4.3 Novogene Co., Ltd. Spatial Transcriptomics Sequencing Revenue, Gross Margin and Market Share (2021-2026)
11.4.4 Novogene Co., Ltd. Main Business Overview
11.4.5 Novogene Co., Ltd. Latest Developments
11.5 STOmics (BGI Spatial)
11.5.1 STOmics (BGI Spatial) Company Information
11.5.2 STOmics (BGI Spatial) Spatial Transcriptomics Sequencing Product Offered
11.5.3 STOmics (BGI Spatial) Spatial Transcriptomics Sequencing Revenue, Gross Margin and Market Share (2021-2026)
11.5.4 STOmics (BGI Spatial) Main Business Overview
11.5.5 STOmics (BGI Spatial) Latest Developments
11.6 Vizgen, Inc.
11.6.1 Vizgen, Inc. Company Information
11.6.2 Vizgen, Inc. Spatial Transcriptomics Sequencing Product Offered
11.6.3 Vizgen, Inc. Spatial Transcriptomics Sequencing Revenue, Gross Margin and Market Share (2021-2026)
11.6.4 Vizgen, Inc. Main Business Overview
11.6.5 Vizgen, Inc. Latest Developments
11.7 Takara Bio Inc.
11.7.1 Takara Bio Inc. Company Information
11.7.2 Takara Bio Inc. Spatial Transcriptomics Sequencing Product Offered
11.7.3 Takara Bio Inc. Spatial Transcriptomics Sequencing Revenue, Gross Margin and Market Share (2021-2026)
11.7.4 Takara Bio Inc. Main Business Overview
11.7.5 Takara Bio Inc. Latest Developments
11.8 Biomarker Technologies Corporation
11.8.1 Biomarker Technologies Corporation Company Information
11.8.2 Biomarker Technologies Corporation Spatial Transcriptomics Sequencing Product Offered
11.8.3 Biomarker Technologies Corporation Spatial Transcriptomics Sequencing Revenue, Gross Margin and Market Share (2021-2026)
11.8.4 Biomarker Technologies Corporation Main Business Overview
11.8.5 Biomarker Technologies Corporation Latest Developments
11.9 LC-Bio Technology Co., Ltd.
11.9.1 LC-Bio Technology Co., Ltd. Company Information
11.9.2 LC-Bio Technology Co., Ltd. Spatial Transcriptomics Sequencing Product Offered
11.9.3 LC-Bio Technology Co., Ltd. Spatial Transcriptomics Sequencing Revenue, Gross Margin and Market Share (2021-2026)
11.9.4 LC-Bio Technology Co., Ltd. Main Business Overview
11.9.5 LC-Bio Technology Co., Ltd. Latest Developments
11.10 Majorbio Bio-Pharm Technology Co., Ltd.
11.10.1 Majorbio Bio-Pharm Technology Co., Ltd. Company Information
11.10.2 Majorbio Bio-Pharm Technology Co., Ltd. Spatial Transcriptomics Sequencing Product Offered
11.10.3 Majorbio Bio-Pharm Technology Co., Ltd. Spatial Transcriptomics Sequencing Revenue, Gross Margin and Market Share (2021-2026)
11.10.4 Majorbio Bio-Pharm Technology Co., Ltd. Main Business Overview
11.10.5 Majorbio Bio-Pharm Technology Co., Ltd. Latest Developments
11.11 Shanghai Biotechnology Corporation
11.11.1 Shanghai Biotechnology Corporation Company Information
11.11.2 Shanghai Biotechnology Corporation Spatial Transcriptomics Sequencing Product Offered
11.11.3 Shanghai Biotechnology Corporation Spatial Transcriptomics Sequencing Revenue, Gross Margin and Market Share (2021-2026)
11.11.4 Shanghai Biotechnology Corporation Main Business Overview
11.11.5 Shanghai Biotechnology Corporation Latest Developments
11.12 Resolve Biosciences GmbH
11.12.1 Resolve Biosciences GmbH Company Information
11.12.2 Resolve Biosciences GmbH Spatial Transcriptomics Sequencing Product Offered
11.12.3 Resolve Biosciences GmbH Spatial Transcriptomics Sequencing Revenue, Gross Margin and Market Share (2021-2026)
11.12.4 Resolve Biosciences GmbH Main Business Overview
11.12.5 Resolve Biosciences GmbH Latest Developments
11.13 Curio Bioscience, Inc.
11.13.1 Curio Bioscience, Inc. Company Information
11.13.2 Curio Bioscience, Inc. Spatial Transcriptomics Sequencing Product Offered
11.13.3 Curio Bioscience, Inc. Spatial Transcriptomics Sequencing Revenue, Gross Margin and Market Share (2021-2026)
11.13.4 Curio Bioscience, Inc. Main Business Overview
11.13.5 Curio Bioscience, Inc. Latest Developments
11.14 Annoroad Gene Technology (Beijing) Co., Ltd.
11.14.1 Annoroad Gene Technology (Beijing) Co., Ltd. Company Information
11.14.2 Annoroad Gene Technology (Beijing) Co., Ltd. Spatial Transcriptomics Sequencing Product Offered
11.14.3 Annoroad Gene Technology (Beijing) Co., Ltd. Spatial Transcriptomics Sequencing Revenue, Gross Margin and Market Share (2021-2026)
11.14.4 Annoroad Gene Technology (Beijing) Co., Ltd. Main Business Overview
11.14.5 Annoroad Gene Technology (Beijing) Co., Ltd. Latest Developments
11.15 OE Biotech Co., Ltd.
11.15.1 OE Biotech Co., Ltd. Company Information
11.15.2 OE Biotech Co., Ltd. Spatial Transcriptomics Sequencing Product Offered
11.15.3 OE Biotech Co., Ltd. Spatial Transcriptomics Sequencing Revenue, Gross Margin and Market Share (2021-2026)
11.15.4 OE Biotech Co., Ltd. Main Business Overview
11.15.5 OE Biotech Co., Ltd. Latest Developments
11.16 NovelBio Bio-Pharm Technology Co., Ltd.
11.16.1 NovelBio Bio-Pharm Technology Co., Ltd. Company Information
11.16.2 NovelBio Bio-Pharm Technology Co., Ltd. Spatial Transcriptomics Sequencing Product Offered
11.16.3 NovelBio Bio-Pharm Technology Co., Ltd. Spatial Transcriptomics Sequencing Revenue, Gross Margin and Market Share (2021-2026)
11.16.4 NovelBio Bio-Pharm Technology Co., Ltd. Main Business Overview
11.16.5 NovelBio Bio-Pharm Technology Co., Ltd. Latest Developments
11.17 OBiO Technology (Shanghai) Corp., Ltd.
11.17.1 OBiO Technology (Shanghai) Corp., Ltd. Company Information
11.17.2 OBiO Technology (Shanghai) Corp., Ltd. Spatial Transcriptomics Sequencing Product Offered
11.17.3 OBiO Technology (Shanghai) Corp., Ltd. Spatial Transcriptomics Sequencing Revenue, Gross Margin and Market Share (2021-2026)
11.17.4 OBiO Technology (Shanghai) Corp., Ltd. Main Business Overview
11.17.5 OBiO Technology (Shanghai) Corp., Ltd. Latest Developments
11.18 Shanghai Jingzhou Gene Technology Co., Ltd. (Sinomics)
11.18.1 Shanghai Jingzhou Gene Technology Co., Ltd. (Sinomics) Company Information
11.18.2 Shanghai Jingzhou Gene Technology Co., Ltd. (Sinomics) Spatial Transcriptomics Sequencing Product Offered
11.18.3 Shanghai Jingzhou Gene Technology Co., Ltd. (Sinomics) Spatial Transcriptomics Sequencing Revenue, Gross Margin and Market Share (2021-2026)
11.18.4 Shanghai Jingzhou Gene Technology Co., Ltd. (Sinomics) Main Business Overview
11.18.5 Shanghai Jingzhou Gene Technology Co., Ltd. (Sinomics) Latest Developments
11.19 RIKEN GENESIS Co., Ltd.
11.19.1 RIKEN GENESIS Co., Ltd. Company Information
11.19.2 RIKEN GENESIS Co., Ltd. Spatial Transcriptomics Sequencing Product Offered
11.19.3 RIKEN GENESIS Co., Ltd. Spatial Transcriptomics Sequencing Revenue, Gross Margin and Market Share (2021-2026)
11.19.4 RIKEN GENESIS Co., Ltd. Main Business Overview
11.19.5 RIKEN GENESIS Co., Ltd. Latest Developments
11.20 Rhelixa, Inc.
11.20.1 Rhelixa, Inc. Company Information
11.20.2 Rhelixa, Inc. Spatial Transcriptomics Sequencing Product Offered
11.20.3 Rhelixa, Inc. Spatial Transcriptomics Sequencing Revenue, Gross Margin and Market Share (2021-2026)
11.20.4 Rhelixa, Inc. Main Business Overview
11.20.5 Rhelixa, Inc. Latest Developments
12 RESEARCH FINDINGS AND CONCLUSION
LIST OF TABLES
Table 1. Spatial Transcriptomics Sequencing Market Size CAGR by Region (2021 VS 2025 VS 2032) & ($ millions)
Table 2. Spatial Transcriptomics Sequencing Annual Sales CAGR by Country/Region (2021, 2025 & 2032) & ($ millions)
Table 3. Major Players of NGS-Based Capture Spatial Transcriptomics
Table 4. Major Players of In Situ Sequencing-Based Spatial Transcriptomics
Table 5. Major Players of Others
Table 6. Spatial Transcriptomics Sequencing Market Size CAGR by Type (2021 VS 2025 VS 2032) & ($ millions)
Table 7. Global Spatial Transcriptomics Sequencing Market Size by Type (2021-2026) & ($ millions)
Table 8. Global Spatial Transcriptomics Sequencing Market Size Market Share by Type (2021-2026)
Table 9. Major Players of Whole-Transcriptome Spatial Profiling
Table 10. Major Players of Targeted High-Plex Spatial Profiling
Table 11. Major Players of Custom Gene-Panel Spatial Profiling
Table 12. Spatial Transcriptomics Sequencing Market Size CAGR by Transcript Coverage (2021 VS 2025 VS 2032) & ($ millions)
Table 13. Global Spatial Transcriptomics Sequencing Market Size by Transcript Coverage (2021-2026) & ($ millions)
Table 14. Global Spatial Transcriptomics Sequencing Market Size Market Share by Transcript Coverage (2021-2026)
Table 15. Major Players of Low Resolution Platform: Spot Diameter > 100 ?m
Table 16. Major Players of Medium Resolution Platform: Spot Diameter 10 ?m – 100 ?m
Table 17. Major Players of Single-Cell High Resolution Platform: Spot Diameter < 10 ?m
Table 18. Spatial Transcriptomics Sequencing Market Size CAGR by Spatial Spot Diameter (2021 VS 2025 VS 2032) & ($ millions)
Table 19. Global Spatial Transcriptomics Sequencing Market Size by Spatial Spot Diameter (2021-2026) & ($ millions)
Table 20. Global Spatial Transcriptomics Sequencing Market Size Market Share by Spatial Spot Diameter (2021-2026)
Table 21. Spatial Transcriptomics Sequencing Market Size CAGR by Application (2021 VS 2025 VS 2032) & ($ millions)
Table 22. Global Spatial Transcriptomics Sequencing Market Size by Application (2021-2026) & ($ millions)
Table 23. Global Spatial Transcriptomics Sequencing Market Size Market Share by Application (2021-2026)
Table 24. Global Spatial Transcriptomics Sequencing Revenue by Player (2021-2026) & ($ millions)
Table 25. Global Spatial Transcriptomics Sequencing Revenue Market Share by Player (2021-2026)
Table 26. Spatial Transcriptomics Sequencing Key Players Head office and Products Offered
Table 27. Spatial Transcriptomics Sequencing Concentration Ratio (CR3, CR5 and CR10) & (2024-2026)
Table 28. New Products and Potential Entrants
Table 29. Mergers & Acquisitions, Expansion
Table 30. Global Spatial Transcriptomics Sequencing Market Size by Region (2021-2026) & ($ millions)
Table 31. Global Spatial Transcriptomics Sequencing Market Size Market Share by Region (2021-2026)
Table 32. Global Spatial Transcriptomics Sequencing Revenue by Country/Region (2021-2026) & ($ millions)
Table 33. Global Spatial Transcriptomics Sequencing Revenue Market Share by Country/Region (2021-2026)
Table 34. Americas Spatial Transcriptomics Sequencing Market Size by Country (2021-2026) & ($ millions)
Table 35. Americas Spatial Transcriptomics Sequencing Market Size Market Share by Country (2021-2026)
Table 36. Americas Spatial Transcriptomics Sequencing Market Size by Type (2021-2026) & ($ millions)
Table 37. Americas Spatial Transcriptomics Sequencing Market Size Market Share by Type (2021-2026)
Table 38. Americas Spatial Transcriptomics Sequencing Market Size by Application (2021-2026) & ($ millions)
Table 39. Americas Spatial Transcriptomics Sequencing Market Size Market Share by Application (2021-2026)
Table 40. APAC Spatial Transcriptomics Sequencing Market Size by Region (2021-2026) & ($ millions)
Table 41. APAC Spatial Transcriptomics Sequencing Market Size Market Share by Region (2021-2026)
Table 42. APAC Spatial Transcriptomics Sequencing Market Size by Type (2021-2026) & ($ millions)
Table 43. APAC Spatial Transcriptomics Sequencing Market Size by Application (2021-2026) & ($ millions)
Table 44. Europe Spatial Transcriptomics Sequencing Market Size by Country (2021-2026) & ($ millions)
Table 45. Europe Spatial Transcriptomics Sequencing Market Size Market Share by Country (2021-2026)
Table 46. Europe Spatial Transcriptomics Sequencing Market Size by Type (2021-2026) & ($ millions)
Table 47. Europe Spatial Transcriptomics Sequencing Market Size by Application (2021-2026) & ($ millions)
Table 48. Middle East & Africa Spatial Transcriptomics Sequencing Market Size by Region (2021-2026) & ($ millions)
Table 49. Middle East & Africa Spatial Transcriptomics Sequencing Market Size by Type (2021-2026) & ($ millions)
Table 50. Middle East & Africa Spatial Transcriptomics Sequencing Market Size by Application (2021-2026) & ($ millions)
Table 51. Key Market Drivers & Growth Opportunities of Spatial Transcriptomics Sequencing
Table 52. Key Market Challenges & Risks of Spatial Transcriptomics Sequencing
Table 53. Key Industry Trends of Spatial Transcriptomics Sequencing
Table 54. Global Spatial Transcriptomics Sequencing Market Size Forecast by Region (2027-2032) & ($ millions)
Table 55. Global Spatial Transcriptomics Sequencing Market Size Market Share Forecast by Region (2027-2032)
Table 56. Global Spatial Transcriptomics Sequencing Market Size Forecast by Type (2027-2032) & ($ millions)
Table 57. Global Spatial Transcriptomics Sequencing Market Size Forecast by Application (2027-2032) & ($ millions)
Table 58. 10x Genomics, Inc. Details, Company Type, Spatial Transcriptomics Sequencing Area Served and Its Competitors
Table 59. 10x Genomics, Inc. Spatial Transcriptomics Sequencing Product Offered
Table 60. 10x Genomics, Inc. Spatial Transcriptomics Sequencing Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 61. 10x Genomics, Inc. Main Business
Table 62. 10x Genomics, Inc. Latest Developments
Table 63. Bruker Spatial Biology Details, Company Type, Spatial Transcriptomics Sequencing Area Served and Its Competitors
Table 64. Bruker Spatial Biology Spatial Transcriptomics Sequencing Product Offered
Table 65. Bruker Spatial Biology Spatial Transcriptomics Sequencing Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 66. Bruker Spatial Biology Main Business
Table 67. Bruker Spatial Biology Latest Developments
Table 68. Illumina, Inc. Details, Company Type, Spatial Transcriptomics Sequencing Area Served and Its Competitors
Table 69. Illumina, Inc. Spatial Transcriptomics Sequencing Product Offered
Table 70. Illumina, Inc. Spatial Transcriptomics Sequencing Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 71. Illumina, Inc. Main Business
Table 72. Illumina, Inc. Latest Developments
Table 73. Novogene Co., Ltd. Details, Company Type, Spatial Transcriptomics Sequencing Area Served and Its Competitors
Table 74. Novogene Co., Ltd. Spatial Transcriptomics Sequencing Product Offered
Table 75. Novogene Co., Ltd. Spatial Transcriptomics Sequencing Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 76. Novogene Co., Ltd. Main Business
Table 77. Novogene Co., Ltd. Latest Developments
Table 78. STOmics (BGI Spatial) Details, Company Type, Spatial Transcriptomics Sequencing Area Served and Its Competitors
Table 79. STOmics (BGI Spatial) Spatial Transcriptomics Sequencing Product Offered
Table 80. STOmics (BGI Spatial) Spatial Transcriptomics Sequencing Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 81. STOmics (BGI Spatial) Main Business
Table 82. STOmics (BGI Spatial) Latest Developments
Table 83. Vizgen, Inc. Details, Company Type, Spatial Transcriptomics Sequencing Area Served and Its Competitors
Table 84. Vizgen, Inc. Spatial Transcriptomics Sequencing Product Offered
Table 85. Vizgen, Inc. Spatial Transcriptomics Sequencing Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 86. Vizgen, Inc. Main Business
Table 87. Vizgen, Inc. Latest Developments
Table 88. Takara Bio Inc. Details, Company Type, Spatial Transcriptomics Sequencing Area Served and Its Competitors
Table 89. Takara Bio Inc. Spatial Transcriptomics Sequencing Product Offered
Table 90. Takara Bio Inc. Spatial Transcriptomics Sequencing Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 91. Takara Bio Inc. Main Business
Table 92. Takara Bio Inc. Latest Developments
Table 93. Biomarker Technologies Corporation Details, Company Type, Spatial Transcriptomics Sequencing Area Served and Its Competitors
Table 94. Biomarker Technologies Corporation Spatial Transcriptomics Sequencing Product Offered
Table 95. Biomarker Technologies Corporation Spatial Transcriptomics Sequencing Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 96. Biomarker Technologies Corporation Main Business
Table 97. Biomarker Technologies Corporation Latest Developments
Table 98. LC-Bio Technology Co., Ltd. Details, Company Type, Spatial Transcriptomics Sequencing Area Served and Its Competitors
Table 99. LC-Bio Technology Co., Ltd. Spatial Transcriptomics Sequencing Product Offered
Table 100. LC-Bio Technology Co., Ltd. Spatial Transcriptomics Sequencing Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 101. LC-Bio Technology Co., Ltd. Main Business
Table 102. LC-Bio Technology Co., Ltd. Latest Developments
Table 103. Majorbio Bio-Pharm Technology Co., Ltd. Details, Company Type, Spatial Transcriptomics Sequencing Area Served and Its Competitors
Table 104. Majorbio Bio-Pharm Technology Co., Ltd. Spatial Transcriptomics Sequencing Product Offered
Table 105. Majorbio Bio-Pharm Technology Co., Ltd. Spatial Transcriptomics Sequencing Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 106. Majorbio Bio-Pharm Technology Co., Ltd. Main Business
Table 107. Majorbio Bio-Pharm Technology Co., Ltd. Latest Developments
Table 108. Shanghai Biotechnology Corporation Details, Company Type, Spatial Transcriptomics Sequencing Area Served and Its Competitors
Table 109. Shanghai Biotechnology Corporation Spatial Transcriptomics Sequencing Product Offered
Table 110. Shanghai Biotechnology Corporation Spatial Transcriptomics Sequencing Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 111. Shanghai Biotechnology Corporation Main Business
Table 112. Shanghai Biotechnology Corporation Latest Developments
Table 113. Resolve Biosciences GmbH Details, Company Type, Spatial Transcriptomics Sequencing Area Served and Its Competitors
Table 114. Resolve Biosciences GmbH Spatial Transcriptomics Sequencing Product Offered
Table 115. Resolve Biosciences GmbH Spatial Transcriptomics Sequencing Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 116. Resolve Biosciences GmbH Main Business
Table 117. Resolve Biosciences GmbH Latest Developments
Table 118. Curio Bioscience, Inc. Details, Company Type, Spatial Transcriptomics Sequencing Area Served and Its Competitors
Table 119. Curio Bioscience, Inc. Spatial Transcriptomics Sequencing Product Offered
Table 120. Curio Bioscience, Inc. Spatial Transcriptomics Sequencing Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 121. Curio Bioscience, Inc. Main Business
Table 122. Curio Bioscience, Inc. Latest Developments
Table 123. Annoroad Gene Technology (Beijing) Co., Ltd. Details, Company Type, Spatial Transcriptomics Sequencing Area Served and Its Competitors
Table 124. Annoroad Gene Technology (Beijing) Co., Ltd. Spatial Transcriptomics Sequencing Product Offered
Table 125. Annoroad Gene Technology (Beijing) Co., Ltd. Spatial Transcriptomics Sequencing Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 126. Annoroad Gene Technology (Beijing) Co., Ltd. Main Business
Table 127. Annoroad Gene Technology (Beijing) Co., Ltd. Latest Developments
Table 128. OE Biotech Co., Ltd. Details, Company Type, Spatial Transcriptomics Sequencing Area Served and Its Competitors
Table 129. OE Biotech Co., Ltd. Spatial Transcriptomics Sequencing Product Offered
Table 130. OE Biotech Co., Ltd. Spatial Transcriptomics Sequencing Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 131. OE Biotech Co., Ltd. Main Business
Table 132. OE Biotech Co., Ltd. Latest Developments
Table 133. NovelBio Bio-Pharm Technology Co., Ltd. Details, Company Type, Spatial Transcriptomics Sequencing Area Served and Its Competitors
Table 134. NovelBio Bio-Pharm Technology Co., Ltd. Spatial Transcriptomics Sequencing Product Offered
Table 135. NovelBio Bio-Pharm Technology Co., Ltd. Spatial Transcriptomics Sequencing Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 136. NovelBio Bio-Pharm Technology Co., Ltd. Main Business
Table 137. NovelBio Bio-Pharm Technology Co., Ltd. Latest Developments
Table 138. OBiO Technology (Shanghai) Corp., Ltd. Details, Company Type, Spatial Transcriptomics Sequencing Area Served and Its Competitors
Table 139. OBiO Technology (Shanghai) Corp., Ltd. Spatial Transcriptomics Sequencing Product Offered
Table 140. OBiO Technology (Shanghai) Corp., Ltd. Spatial Transcriptomics Sequencing Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 141. OBiO Technology (Shanghai) Corp., Ltd. Main Business
Table 142. OBiO Technology (Shanghai) Corp., Ltd. Latest Developments
Table 143. Shanghai Jingzhou Gene Technology Co., Ltd. (Sinomics) Details, Company Type, Spatial Transcriptomics Sequencing Area Served and Its Competitors
Table 144. Shanghai Jingzhou Gene Technology Co., Ltd. (Sinomics) Spatial Transcriptomics Sequencing Product Offered
Table 145. Shanghai Jingzhou Gene Technology Co., Ltd. (Sinomics) Spatial Transcriptomics Sequencing Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 146. Shanghai Jingzhou Gene Technology Co., Ltd. (Sinomics) Main Business
Table 147. Shanghai Jingzhou Gene Technology Co., Ltd. (Sinomics) Latest Developments
Table 148. RIKEN GENESIS Co., Ltd. Details, Company Type, Spatial Transcriptomics Sequencing Area Served and Its Competitors
Table 149. RIKEN GENESIS Co., Ltd. Spatial Transcriptomics Sequencing Product Offered
Table 150. RIKEN GENESIS Co., Ltd. Spatial Transcriptomics Sequencing Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 151. RIKEN GENESIS Co., Ltd. Main Business
Table 152. RIKEN GENESIS Co., Ltd. Latest Developments
Table 153. Rhelixa, Inc. Details, Company Type, Spatial Transcriptomics Sequencing Area Served and Its Competitors
Table 154. Rhelixa, Inc. Spatial Transcriptomics Sequencing Product Offered
Table 155. Rhelixa, Inc. Spatial Transcriptomics Sequencing Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 156. Rhelixa, Inc. Main Business
Table 157. Rhelixa, Inc. Latest Developments
Table 1. Spatial Transcriptomics Sequencing Market Size CAGR by Region (2021 VS 2025 VS 2032) & ($ millions)
Table 2. Spatial Transcriptomics Sequencing Annual Sales CAGR by Country/Region (2021, 2025 & 2032) & ($ millions)
Table 3. Major Players of NGS-Based Capture Spatial Transcriptomics
Table 4. Major Players of In Situ Sequencing-Based Spatial Transcriptomics
Table 5. Major Players of Others
Table 6. Spatial Transcriptomics Sequencing Market Size CAGR by Type (2021 VS 2025 VS 2032) & ($ millions)
Table 7. Global Spatial Transcriptomics Sequencing Market Size by Type (2021-2026) & ($ millions)
Table 8. Global Spatial Transcriptomics Sequencing Market Size Market Share by Type (2021-2026)
Table 9. Major Players of Whole-Transcriptome Spatial Profiling
Table 10. Major Players of Targeted High-Plex Spatial Profiling
Table 11. Major Players of Custom Gene-Panel Spatial Profiling
Table 12. Spatial Transcriptomics Sequencing Market Size CAGR by Transcript Coverage (2021 VS 2025 VS 2032) & ($ millions)
Table 13. Global Spatial Transcriptomics Sequencing Market Size by Transcript Coverage (2021-2026) & ($ millions)
Table 14. Global Spatial Transcriptomics Sequencing Market Size Market Share by Transcript Coverage (2021-2026)
Table 15. Major Players of Low Resolution Platform: Spot Diameter > 100 ?m
Table 16. Major Players of Medium Resolution Platform: Spot Diameter 10 ?m – 100 ?m
Table 17. Major Players of Single-Cell High Resolution Platform: Spot Diameter < 10 ?m
Table 18. Spatial Transcriptomics Sequencing Market Size CAGR by Spatial Spot Diameter (2021 VS 2025 VS 2032) & ($ millions)
Table 19. Global Spatial Transcriptomics Sequencing Market Size by Spatial Spot Diameter (2021-2026) & ($ millions)
Table 20. Global Spatial Transcriptomics Sequencing Market Size Market Share by Spatial Spot Diameter (2021-2026)
Table 21. Spatial Transcriptomics Sequencing Market Size CAGR by Application (2021 VS 2025 VS 2032) & ($ millions)
Table 22. Global Spatial Transcriptomics Sequencing Market Size by Application (2021-2026) & ($ millions)
Table 23. Global Spatial Transcriptomics Sequencing Market Size Market Share by Application (2021-2026)
Table 24. Global Spatial Transcriptomics Sequencing Revenue by Player (2021-2026) & ($ millions)
Table 25. Global Spatial Transcriptomics Sequencing Revenue Market Share by Player (2021-2026)
Table 26. Spatial Transcriptomics Sequencing Key Players Head office and Products Offered
Table 27. Spatial Transcriptomics Sequencing Concentration Ratio (CR3, CR5 and CR10) & (2024-2026)
Table 28. New Products and Potential Entrants
Table 29. Mergers & Acquisitions, Expansion
Table 30. Global Spatial Transcriptomics Sequencing Market Size by Region (2021-2026) & ($ millions)
Table 31. Global Spatial Transcriptomics Sequencing Market Size Market Share by Region (2021-2026)
Table 32. Global Spatial Transcriptomics Sequencing Revenue by Country/Region (2021-2026) & ($ millions)
Table 33. Global Spatial Transcriptomics Sequencing Revenue Market Share by Country/Region (2021-2026)
Table 34. Americas Spatial Transcriptomics Sequencing Market Size by Country (2021-2026) & ($ millions)
Table 35. Americas Spatial Transcriptomics Sequencing Market Size Market Share by Country (2021-2026)
Table 36. Americas Spatial Transcriptomics Sequencing Market Size by Type (2021-2026) & ($ millions)
Table 37. Americas Spatial Transcriptomics Sequencing Market Size Market Share by Type (2021-2026)
Table 38. Americas Spatial Transcriptomics Sequencing Market Size by Application (2021-2026) & ($ millions)
Table 39. Americas Spatial Transcriptomics Sequencing Market Size Market Share by Application (2021-2026)
Table 40. APAC Spatial Transcriptomics Sequencing Market Size by Region (2021-2026) & ($ millions)
Table 41. APAC Spatial Transcriptomics Sequencing Market Size Market Share by Region (2021-2026)
Table 42. APAC Spatial Transcriptomics Sequencing Market Size by Type (2021-2026) & ($ millions)
Table 43. APAC Spatial Transcriptomics Sequencing Market Size by Application (2021-2026) & ($ millions)
Table 44. Europe Spatial Transcriptomics Sequencing Market Size by Country (2021-2026) & ($ millions)
Table 45. Europe Spatial Transcriptomics Sequencing Market Size Market Share by Country (2021-2026)
Table 46. Europe Spatial Transcriptomics Sequencing Market Size by Type (2021-2026) & ($ millions)
Table 47. Europe Spatial Transcriptomics Sequencing Market Size by Application (2021-2026) & ($ millions)
Table 48. Middle East & Africa Spatial Transcriptomics Sequencing Market Size by Region (2021-2026) & ($ millions)
Table 49. Middle East & Africa Spatial Transcriptomics Sequencing Market Size by Type (2021-2026) & ($ millions)
Table 50. Middle East & Africa Spatial Transcriptomics Sequencing Market Size by Application (2021-2026) & ($ millions)
Table 51. Key Market Drivers & Growth Opportunities of Spatial Transcriptomics Sequencing
Table 52. Key Market Challenges & Risks of Spatial Transcriptomics Sequencing
Table 53. Key Industry Trends of Spatial Transcriptomics Sequencing
Table 54. Global Spatial Transcriptomics Sequencing Market Size Forecast by Region (2027-2032) & ($ millions)
Table 55. Global Spatial Transcriptomics Sequencing Market Size Market Share Forecast by Region (2027-2032)
Table 56. Global Spatial Transcriptomics Sequencing Market Size Forecast by Type (2027-2032) & ($ millions)
Table 57. Global Spatial Transcriptomics Sequencing Market Size Forecast by Application (2027-2032) & ($ millions)
Table 58. 10x Genomics, Inc. Details, Company Type, Spatial Transcriptomics Sequencing Area Served and Its Competitors
Table 59. 10x Genomics, Inc. Spatial Transcriptomics Sequencing Product Offered
Table 60. 10x Genomics, Inc. Spatial Transcriptomics Sequencing Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 61. 10x Genomics, Inc. Main Business
Table 62. 10x Genomics, Inc. Latest Developments
Table 63. Bruker Spatial Biology Details, Company Type, Spatial Transcriptomics Sequencing Area Served and Its Competitors
Table 64. Bruker Spatial Biology Spatial Transcriptomics Sequencing Product Offered
Table 65. Bruker Spatial Biology Spatial Transcriptomics Sequencing Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 66. Bruker Spatial Biology Main Business
Table 67. Bruker Spatial Biology Latest Developments
Table 68. Illumina, Inc. Details, Company Type, Spatial Transcriptomics Sequencing Area Served and Its Competitors
Table 69. Illumina, Inc. Spatial Transcriptomics Sequencing Product Offered
Table 70. Illumina, Inc. Spatial Transcriptomics Sequencing Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 71. Illumina, Inc. Main Business
Table 72. Illumina, Inc. Latest Developments
Table 73. Novogene Co., Ltd. Details, Company Type, Spatial Transcriptomics Sequencing Area Served and Its Competitors
Table 74. Novogene Co., Ltd. Spatial Transcriptomics Sequencing Product Offered
Table 75. Novogene Co., Ltd. Spatial Transcriptomics Sequencing Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 76. Novogene Co., Ltd. Main Business
Table 77. Novogene Co., Ltd. Latest Developments
Table 78. STOmics (BGI Spatial) Details, Company Type, Spatial Transcriptomics Sequencing Area Served and Its Competitors
Table 79. STOmics (BGI Spatial) Spatial Transcriptomics Sequencing Product Offered
Table 80. STOmics (BGI Spatial) Spatial Transcriptomics Sequencing Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 81. STOmics (BGI Spatial) Main Business
Table 82. STOmics (BGI Spatial) Latest Developments
Table 83. Vizgen, Inc. Details, Company Type, Spatial Transcriptomics Sequencing Area Served and Its Competitors
Table 84. Vizgen, Inc. Spatial Transcriptomics Sequencing Product Offered
Table 85. Vizgen, Inc. Spatial Transcriptomics Sequencing Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 86. Vizgen, Inc. Main Business
Table 87. Vizgen, Inc. Latest Developments
Table 88. Takara Bio Inc. Details, Company Type, Spatial Transcriptomics Sequencing Area Served and Its Competitors
Table 89. Takara Bio Inc. Spatial Transcriptomics Sequencing Product Offered
Table 90. Takara Bio Inc. Spatial Transcriptomics Sequencing Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 91. Takara Bio Inc. Main Business
Table 92. Takara Bio Inc. Latest Developments
Table 93. Biomarker Technologies Corporation Details, Company Type, Spatial Transcriptomics Sequencing Area Served and Its Competitors
Table 94. Biomarker Technologies Corporation Spatial Transcriptomics Sequencing Product Offered
Table 95. Biomarker Technologies Corporation Spatial Transcriptomics Sequencing Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 96. Biomarker Technologies Corporation Main Business
Table 97. Biomarker Technologies Corporation Latest Developments
Table 98. LC-Bio Technology Co., Ltd. Details, Company Type, Spatial Transcriptomics Sequencing Area Served and Its Competitors
Table 99. LC-Bio Technology Co., Ltd. Spatial Transcriptomics Sequencing Product Offered
Table 100. LC-Bio Technology Co., Ltd. Spatial Transcriptomics Sequencing Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 101. LC-Bio Technology Co., Ltd. Main Business
Table 102. LC-Bio Technology Co., Ltd. Latest Developments
Table 103. Majorbio Bio-Pharm Technology Co., Ltd. Details, Company Type, Spatial Transcriptomics Sequencing Area Served and Its Competitors
Table 104. Majorbio Bio-Pharm Technology Co., Ltd. Spatial Transcriptomics Sequencing Product Offered
Table 105. Majorbio Bio-Pharm Technology Co., Ltd. Spatial Transcriptomics Sequencing Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 106. Majorbio Bio-Pharm Technology Co., Ltd. Main Business
Table 107. Majorbio Bio-Pharm Technology Co., Ltd. Latest Developments
Table 108. Shanghai Biotechnology Corporation Details, Company Type, Spatial Transcriptomics Sequencing Area Served and Its Competitors
Table 109. Shanghai Biotechnology Corporation Spatial Transcriptomics Sequencing Product Offered
Table 110. Shanghai Biotechnology Corporation Spatial Transcriptomics Sequencing Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 111. Shanghai Biotechnology Corporation Main Business
Table 112. Shanghai Biotechnology Corporation Latest Developments
Table 113. Resolve Biosciences GmbH Details, Company Type, Spatial Transcriptomics Sequencing Area Served and Its Competitors
Table 114. Resolve Biosciences GmbH Spatial Transcriptomics Sequencing Product Offered
Table 115. Resolve Biosciences GmbH Spatial Transcriptomics Sequencing Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 116. Resolve Biosciences GmbH Main Business
Table 117. Resolve Biosciences GmbH Latest Developments
Table 118. Curio Bioscience, Inc. Details, Company Type, Spatial Transcriptomics Sequencing Area Served and Its Competitors
Table 119. Curio Bioscience, Inc. Spatial Transcriptomics Sequencing Product Offered
Table 120. Curio Bioscience, Inc. Spatial Transcriptomics Sequencing Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 121. Curio Bioscience, Inc. Main Business
Table 122. Curio Bioscience, Inc. Latest Developments
Table 123. Annoroad Gene Technology (Beijing) Co., Ltd. Details, Company Type, Spatial Transcriptomics Sequencing Area Served and Its Competitors
Table 124. Annoroad Gene Technology (Beijing) Co., Ltd. Spatial Transcriptomics Sequencing Product Offered
Table 125. Annoroad Gene Technology (Beijing) Co., Ltd. Spatial Transcriptomics Sequencing Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 126. Annoroad Gene Technology (Beijing) Co., Ltd. Main Business
Table 127. Annoroad Gene Technology (Beijing) Co., Ltd. Latest Developments
Table 128. OE Biotech Co., Ltd. Details, Company Type, Spatial Transcriptomics Sequencing Area Served and Its Competitors
Table 129. OE Biotech Co., Ltd. Spatial Transcriptomics Sequencing Product Offered
Table 130. OE Biotech Co., Ltd. Spatial Transcriptomics Sequencing Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 131. OE Biotech Co., Ltd. Main Business
Table 132. OE Biotech Co., Ltd. Latest Developments
Table 133. NovelBio Bio-Pharm Technology Co., Ltd. Details, Company Type, Spatial Transcriptomics Sequencing Area Served and Its Competitors
Table 134. NovelBio Bio-Pharm Technology Co., Ltd. Spatial Transcriptomics Sequencing Product Offered
Table 135. NovelBio Bio-Pharm Technology Co., Ltd. Spatial Transcriptomics Sequencing Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 136. NovelBio Bio-Pharm Technology Co., Ltd. Main Business
Table 137. NovelBio Bio-Pharm Technology Co., Ltd. Latest Developments
Table 138. OBiO Technology (Shanghai) Corp., Ltd. Details, Company Type, Spatial Transcriptomics Sequencing Area Served and Its Competitors
Table 139. OBiO Technology (Shanghai) Corp., Ltd. Spatial Transcriptomics Sequencing Product Offered
Table 140. OBiO Technology (Shanghai) Corp., Ltd. Spatial Transcriptomics Sequencing Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 141. OBiO Technology (Shanghai) Corp., Ltd. Main Business
Table 142. OBiO Technology (Shanghai) Corp., Ltd. Latest Developments
Table 143. Shanghai Jingzhou Gene Technology Co., Ltd. (Sinomics) Details, Company Type, Spatial Transcriptomics Sequencing Area Served and Its Competitors
Table 144. Shanghai Jingzhou Gene Technology Co., Ltd. (Sinomics) Spatial Transcriptomics Sequencing Product Offered
Table 145. Shanghai Jingzhou Gene Technology Co., Ltd. (Sinomics) Spatial Transcriptomics Sequencing Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 146. Shanghai Jingzhou Gene Technology Co., Ltd. (Sinomics) Main Business
Table 147. Shanghai Jingzhou Gene Technology Co., Ltd. (Sinomics) Latest Developments
Table 148. RIKEN GENESIS Co., Ltd. Details, Company Type, Spatial Transcriptomics Sequencing Area Served and Its Competitors
Table 149. RIKEN GENESIS Co., Ltd. Spatial Transcriptomics Sequencing Product Offered
Table 150. RIKEN GENESIS Co., Ltd. Spatial Transcriptomics Sequencing Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 151. RIKEN GENESIS Co., Ltd. Main Business
Table 152. RIKEN GENESIS Co., Ltd. Latest Developments
Table 153. Rhelixa, Inc. Details, Company Type, Spatial Transcriptomics Sequencing Area Served and Its Competitors
Table 154. Rhelixa, Inc. Spatial Transcriptomics Sequencing Product Offered
Table 155. Rhelixa, Inc. Spatial Transcriptomics Sequencing Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 156. Rhelixa, Inc. Main Business
Table 157. Rhelixa, Inc. Latest Developments
LIST OF FIGURES
Figure 1. Spatial Transcriptomics Sequencing Report Years Considered
Figure 2. Research Objectives
Figure 3. Research Methodology
Figure 4. Research Process and Data Source
Figure 5. Global Spatial Transcriptomics Sequencing Market Size Growth Rate (2021-2032) ($ millions)
Figure 6. Spatial Transcriptomics Sequencing Sales by Geographic Region (2021, 2025 & 2032) & ($ millions)
Figure 7. Spatial Transcriptomics Sequencing Sales Market Share by Country/Region (2025)
Figure 8. Spatial Transcriptomics Sequencing Sales Market Share by Country/Region (2021, 2025 & 2032)
Figure 9. Global Spatial Transcriptomics Sequencing Market Size Market Share by Type in 2025
Figure 10. Global Spatial Transcriptomics Sequencing Market Size Market Share by Transcript Coverage in 2025
Figure 11. Global Spatial Transcriptomics Sequencing Market Size Market Share by Spatial Spot Diameter in 2025
Figure 12. Spatial Transcriptomics Sequencing in Cancer Research
Figure 13. Global Spatial Transcriptomics Sequencing Market: Cancer Research (2021-2026) & ($ millions)
Figure 14. Spatial Transcriptomics Sequencing in Developmental Biology
Figure 15. Global Spatial Transcriptomics Sequencing Market: Developmental Biology (2021-2026) & ($ millions)
Figure 16. Spatial Transcriptomics Sequencing in Neuroscience
Figure 17. Global Spatial Transcriptomics Sequencing Market: Neuroscience (2021-2026) & ($ millions)
Figure 18. Spatial Transcriptomics Sequencing in Other
Figure 19. Global Spatial Transcriptomics Sequencing Market: Other (2021-2026) & ($ millions)
Figure 20. Global Spatial Transcriptomics Sequencing Market Size Market Share by Application in 2025
Figure 21. Global Spatial Transcriptomics Sequencing Revenue Market Share by Player in 2025
Figure 22. Global Spatial Transcriptomics Sequencing Market Size Market Share by Region (2021-2026)
Figure 23. Americas Spatial Transcriptomics Sequencing Market Size 2021-2026 ($ millions)
Figure 24. APAC Spatial Transcriptomics Sequencing Market Size 2021-2026 ($ millions)
Figure 25. Europe Spatial Transcriptomics Sequencing Market Size 2021-2026 ($ millions)
Figure 26. Middle East & Africa Spatial Transcriptomics Sequencing Market Size 2021-2026 ($ millions)
Figure 27. Americas Spatial Transcriptomics Sequencing Value Market Share by Country in 2025
Figure 28. United States Spatial Transcriptomics Sequencing Market Size Growth 2021-2026 ($ millions)
Figure 29. Canada Spatial Transcriptomics Sequencing Market Size Growth 2021-2026 ($ millions)
Figure 30. Mexico Spatial Transcriptomics Sequencing Market Size Growth 2021-2026 ($ millions)
Figure 31. Brazil Spatial Transcriptomics Sequencing Market Size Growth 2021-2026 ($ millions)
Figure 32. APAC Spatial Transcriptomics Sequencing Market Size Market Share by Region in 2025
Figure 33. APAC Spatial Transcriptomics Sequencing Market Size Market Share by Type (2021-2026)
Figure 34. APAC Spatial Transcriptomics Sequencing Market Size Market Share by Application (2021-2026)
Figure 35. China Spatial Transcriptomics Sequencing Market Size Growth 2021-2026 ($ millions)
Figure 36. Japan Spatial Transcriptomics Sequencing Market Size Growth 2021-2026 ($ millions)
Figure 37. South Korea Spatial Transcriptomics Sequencing Market Size Growth 2021-2026 ($ millions)
Figure 38. Southeast Asia Spatial Transcriptomics Sequencing Market Size Growth 2021-2026 ($ millions)
Figure 39. India Spatial Transcriptomics Sequencing Market Size Growth 2021-2026 ($ millions)
Figure 40. Australia Spatial Transcriptomics Sequencing Market Size Growth 2021-2026 ($ millions)
Figure 41. Europe Spatial Transcriptomics Sequencing Market Size Market Share by Country in 2025
Figure 42. Europe Spatial Transcriptomics Sequencing Market Size Market Share by Type (2021-2026)
Figure 43. Europe Spatial Transcriptomics Sequencing Market Size Market Share by Application (2021-2026)
Figure 44. Germany Spatial Transcriptomics Sequencing Market Size Growth 2021-2026 ($ millions)
Figure 45. France Spatial Transcriptomics Sequencing Market Size Growth 2021-2026 ($ millions)
Figure 46. UK Spatial Transcriptomics Sequencing Market Size Growth 2021-2026 ($ millions)
Figure 47. Italy Spatial Transcriptomics Sequencing Market Size Growth 2021-2026 ($ millions)
Figure 48. Russia Spatial Transcriptomics Sequencing Market Size Growth 2021-2026 ($ millions)
Figure 49. Middle East & Africa Spatial Transcriptomics Sequencing Market Size Market Share by Region (2021-2026)
Figure 50. Middle East & Africa Spatial Transcriptomics Sequencing Market Size Market Share by Type (2021-2026)
Figure 51. Middle East & Africa Spatial Transcriptomics Sequencing Market Size Market Share by Application (2021-2026)
Figure 52. Egypt Spatial Transcriptomics Sequencing Market Size Growth 2021-2026 ($ millions)
Figure 53. South Africa Spatial Transcriptomics Sequencing Market Size Growth 2021-2026 ($ millions)
Figure 54. Israel Spatial Transcriptomics Sequencing Market Size Growth 2021-2026 ($ millions)
Figure 55. Turkey Spatial Transcriptomics Sequencing Market Size Growth 2021-2026 ($ millions)
Figure 56. GCC Countries Spatial Transcriptomics Sequencing Market Size Growth 2021-2026 ($ millions)
Figure 57. Americas Spatial Transcriptomics Sequencing Market Size 2027-2032 ($ millions)
Figure 58. APAC Spatial Transcriptomics Sequencing Market Size 2027-2032 ($ millions)
Figure 59. Europe Spatial Transcriptomics Sequencing Market Size 2027-2032 ($ millions)
Figure 60. Middle East & Africa Spatial Transcriptomics Sequencing Market Size 2027-2032 ($ millions)
Figure 61. United States Spatial Transcriptomics Sequencing Market Size 2027-2032 ($ millions)
Figure 62. Canada Spatial Transcriptomics Sequencing Market Size 2027-2032 ($ millions)
Figure 63. Mexico Spatial Transcriptomics Sequencing Market Size 2027-2032 ($ millions)
Figure 64. Brazil Spatial Transcriptomics Sequencing Market Size 2027-2032 ($ millions)
Figure 65. China Spatial Transcriptomics Sequencing Market Size 2027-2032 ($ millions)
Figure 66. Japan Spatial Transcriptomics Sequencing Market Size 2027-2032 ($ millions)
Figure 67. Korea Spatial Transcriptomics Sequencing Market Size 2027-2032 ($ millions)
Figure 68. Southeast Asia Spatial Transcriptomics Sequencing Market Size 2027-2032 ($ millions)
Figure 69. India Spatial Transcriptomics Sequencing Market Size 2027-2032 ($ millions)
Figure 70. Australia Spatial Transcriptomics Sequencing Market Size 2027-2032 ($ millions)
Figure 71. Germany Spatial Transcriptomics Sequencing Market Size 2027-2032 ($ millions)
Figure 72. France Spatial Transcriptomics Sequencing Market Size 2027-2032 ($ millions)
Figure 73. UK Spatial Transcriptomics Sequencing Market Size 2027-2032 ($ millions)
Figure 74. Italy Spatial Transcriptomics Sequencing Market Size 2027-2032 ($ millions)
Figure 75. Russia Spatial Transcriptomics Sequencing Market Size 2027-2032 ($ millions)
Figure 76. Egypt Spatial Transcriptomics Sequencing Market Size 2027-2032 ($ millions)
Figure 77. South Africa Spatial Transcriptomics Sequencing Market Size 2027-2032 ($ millions)
Figure 78. Israel Spatial Transcriptomics Sequencing Market Size 2027-2032 ($ millions)
Figure 79. Turkey Spatial Transcriptomics Sequencing Market Size 2027-2032 ($ millions)
Figure 80. Global Spatial Transcriptomics Sequencing Market Size Market Share Forecast by Type (2027-2032)
Figure 81. Global Spatial Transcriptomics Sequencing Market Size Market Share Forecast by Application (2027-2032)
Figure 82. GCC Countries Spatial Transcriptomics Sequencing Market Size 2027-2032 ($ millions)
Figure 1. Spatial Transcriptomics Sequencing Report Years Considered
Figure 2. Research Objectives
Figure 3. Research Methodology
Figure 4. Research Process and Data Source
Figure 5. Global Spatial Transcriptomics Sequencing Market Size Growth Rate (2021-2032) ($ millions)
Figure 6. Spatial Transcriptomics Sequencing Sales by Geographic Region (2021, 2025 & 2032) & ($ millions)
Figure 7. Spatial Transcriptomics Sequencing Sales Market Share by Country/Region (2025)
Figure 8. Spatial Transcriptomics Sequencing Sales Market Share by Country/Region (2021, 2025 & 2032)
Figure 9. Global Spatial Transcriptomics Sequencing Market Size Market Share by Type in 2025
Figure 10. Global Spatial Transcriptomics Sequencing Market Size Market Share by Transcript Coverage in 2025
Figure 11. Global Spatial Transcriptomics Sequencing Market Size Market Share by Spatial Spot Diameter in 2025
Figure 12. Spatial Transcriptomics Sequencing in Cancer Research
Figure 13. Global Spatial Transcriptomics Sequencing Market: Cancer Research (2021-2026) & ($ millions)
Figure 14. Spatial Transcriptomics Sequencing in Developmental Biology
Figure 15. Global Spatial Transcriptomics Sequencing Market: Developmental Biology (2021-2026) & ($ millions)
Figure 16. Spatial Transcriptomics Sequencing in Neuroscience
Figure 17. Global Spatial Transcriptomics Sequencing Market: Neuroscience (2021-2026) & ($ millions)
Figure 18. Spatial Transcriptomics Sequencing in Other
Figure 19. Global Spatial Transcriptomics Sequencing Market: Other (2021-2026) & ($ millions)
Figure 20. Global Spatial Transcriptomics Sequencing Market Size Market Share by Application in 2025
Figure 21. Global Spatial Transcriptomics Sequencing Revenue Market Share by Player in 2025
Figure 22. Global Spatial Transcriptomics Sequencing Market Size Market Share by Region (2021-2026)
Figure 23. Americas Spatial Transcriptomics Sequencing Market Size 2021-2026 ($ millions)
Figure 24. APAC Spatial Transcriptomics Sequencing Market Size 2021-2026 ($ millions)
Figure 25. Europe Spatial Transcriptomics Sequencing Market Size 2021-2026 ($ millions)
Figure 26. Middle East & Africa Spatial Transcriptomics Sequencing Market Size 2021-2026 ($ millions)
Figure 27. Americas Spatial Transcriptomics Sequencing Value Market Share by Country in 2025
Figure 28. United States Spatial Transcriptomics Sequencing Market Size Growth 2021-2026 ($ millions)
Figure 29. Canada Spatial Transcriptomics Sequencing Market Size Growth 2021-2026 ($ millions)
Figure 30. Mexico Spatial Transcriptomics Sequencing Market Size Growth 2021-2026 ($ millions)
Figure 31. Brazil Spatial Transcriptomics Sequencing Market Size Growth 2021-2026 ($ millions)
Figure 32. APAC Spatial Transcriptomics Sequencing Market Size Market Share by Region in 2025
Figure 33. APAC Spatial Transcriptomics Sequencing Market Size Market Share by Type (2021-2026)
Figure 34. APAC Spatial Transcriptomics Sequencing Market Size Market Share by Application (2021-2026)
Figure 35. China Spatial Transcriptomics Sequencing Market Size Growth 2021-2026 ($ millions)
Figure 36. Japan Spatial Transcriptomics Sequencing Market Size Growth 2021-2026 ($ millions)
Figure 37. South Korea Spatial Transcriptomics Sequencing Market Size Growth 2021-2026 ($ millions)
Figure 38. Southeast Asia Spatial Transcriptomics Sequencing Market Size Growth 2021-2026 ($ millions)
Figure 39. India Spatial Transcriptomics Sequencing Market Size Growth 2021-2026 ($ millions)
Figure 40. Australia Spatial Transcriptomics Sequencing Market Size Growth 2021-2026 ($ millions)
Figure 41. Europe Spatial Transcriptomics Sequencing Market Size Market Share by Country in 2025
Figure 42. Europe Spatial Transcriptomics Sequencing Market Size Market Share by Type (2021-2026)
Figure 43. Europe Spatial Transcriptomics Sequencing Market Size Market Share by Application (2021-2026)
Figure 44. Germany Spatial Transcriptomics Sequencing Market Size Growth 2021-2026 ($ millions)
Figure 45. France Spatial Transcriptomics Sequencing Market Size Growth 2021-2026 ($ millions)
Figure 46. UK Spatial Transcriptomics Sequencing Market Size Growth 2021-2026 ($ millions)
Figure 47. Italy Spatial Transcriptomics Sequencing Market Size Growth 2021-2026 ($ millions)
Figure 48. Russia Spatial Transcriptomics Sequencing Market Size Growth 2021-2026 ($ millions)
Figure 49. Middle East & Africa Spatial Transcriptomics Sequencing Market Size Market Share by Region (2021-2026)
Figure 50. Middle East & Africa Spatial Transcriptomics Sequencing Market Size Market Share by Type (2021-2026)
Figure 51. Middle East & Africa Spatial Transcriptomics Sequencing Market Size Market Share by Application (2021-2026)
Figure 52. Egypt Spatial Transcriptomics Sequencing Market Size Growth 2021-2026 ($ millions)
Figure 53. South Africa Spatial Transcriptomics Sequencing Market Size Growth 2021-2026 ($ millions)
Figure 54. Israel Spatial Transcriptomics Sequencing Market Size Growth 2021-2026 ($ millions)
Figure 55. Turkey Spatial Transcriptomics Sequencing Market Size Growth 2021-2026 ($ millions)
Figure 56. GCC Countries Spatial Transcriptomics Sequencing Market Size Growth 2021-2026 ($ millions)
Figure 57. Americas Spatial Transcriptomics Sequencing Market Size 2027-2032 ($ millions)
Figure 58. APAC Spatial Transcriptomics Sequencing Market Size 2027-2032 ($ millions)
Figure 59. Europe Spatial Transcriptomics Sequencing Market Size 2027-2032 ($ millions)
Figure 60. Middle East & Africa Spatial Transcriptomics Sequencing Market Size 2027-2032 ($ millions)
Figure 61. United States Spatial Transcriptomics Sequencing Market Size 2027-2032 ($ millions)
Figure 62. Canada Spatial Transcriptomics Sequencing Market Size 2027-2032 ($ millions)
Figure 63. Mexico Spatial Transcriptomics Sequencing Market Size 2027-2032 ($ millions)
Figure 64. Brazil Spatial Transcriptomics Sequencing Market Size 2027-2032 ($ millions)
Figure 65. China Spatial Transcriptomics Sequencing Market Size 2027-2032 ($ millions)
Figure 66. Japan Spatial Transcriptomics Sequencing Market Size 2027-2032 ($ millions)
Figure 67. Korea Spatial Transcriptomics Sequencing Market Size 2027-2032 ($ millions)
Figure 68. Southeast Asia Spatial Transcriptomics Sequencing Market Size 2027-2032 ($ millions)
Figure 69. India Spatial Transcriptomics Sequencing Market Size 2027-2032 ($ millions)
Figure 70. Australia Spatial Transcriptomics Sequencing Market Size 2027-2032 ($ millions)
Figure 71. Germany Spatial Transcriptomics Sequencing Market Size 2027-2032 ($ millions)
Figure 72. France Spatial Transcriptomics Sequencing Market Size 2027-2032 ($ millions)
Figure 73. UK Spatial Transcriptomics Sequencing Market Size 2027-2032 ($ millions)
Figure 74. Italy Spatial Transcriptomics Sequencing Market Size 2027-2032 ($ millions)
Figure 75. Russia Spatial Transcriptomics Sequencing Market Size 2027-2032 ($ millions)
Figure 76. Egypt Spatial Transcriptomics Sequencing Market Size 2027-2032 ($ millions)
Figure 77. South Africa Spatial Transcriptomics Sequencing Market Size 2027-2032 ($ millions)
Figure 78. Israel Spatial Transcriptomics Sequencing Market Size 2027-2032 ($ millions)
Figure 79. Turkey Spatial Transcriptomics Sequencing Market Size 2027-2032 ($ millions)
Figure 80. Global Spatial Transcriptomics Sequencing Market Size Market Share Forecast by Type (2027-2032)
Figure 81. Global Spatial Transcriptomics Sequencing Market Size Market Share Forecast by Application (2027-2032)
Figure 82. GCC Countries Spatial Transcriptomics Sequencing Market Size 2027-2032 ($ millions)
